Advertisement

Literatur

  • Joachim Schrader

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Aasen AO, Ohlsson K, Larsbraaten M, Amundsen E (1978) Changes in plasminogen levels, plasmin activity and activity of antiplasmin during endotoxin shock in dogs. Eur Surg Res 10: 63–72PubMedCrossRefGoogle Scholar
  2. 2.
    Aasen AO, Dale J, Ohlsson K, Gallimore M (1978) Effects of slow intravenous administration of endotoxin on blood cells and coagulation in dogs. Eur Surg Res 10:194–205PubMedCrossRefGoogle Scholar
  3. 3.
    Aasen AO, Smith-Erichsen N, Amundsen E (1985) Studies on pathological plasma proteolysis in patients with septicemia. Scand J Clin Lab Invest [Suppl 178] 45: 37–45CrossRefGoogle Scholar
  4. 4.
    Addis T (1948) Glomerular nephritis. MacMillian, New YorkGoogle Scholar
  5. 5.
    Ambruso DR, Durante DP, Mcintosh RM, Hathaway WE (1977) Factor VIII and renal disease. Ann Intern Med 87: 636–637PubMedGoogle Scholar
  6. 6.
    Amery AH, Pegrum GD, Risdon RA, Williams G (1973) Nature of hyperacute (accelerated second set) rejection in dog renal allografts and effects of heparin on rejection process. Br Med J I: 455–458CrossRefGoogle Scholar
  7. 7.
    Anderson M, Dewar P, Fleming LB et al. (1974) A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection. Clin Nephrol 2: 93–99PubMedGoogle Scholar
  8. 8.
    Andrassy K (1979) Nephrologie and Hämostase. Aktuel Nephrol 12: 635–647Google Scholar
  9. 9.
    Andrassy K, Ritz E (1985) Uremia as a cause of bleeding. Am J Nephrol 5: 313–319PubMedCrossRefGoogle Scholar
  10. 10.
    Andrassy K, Buchholz L, Bleyl U, Ritz E, Seidel D (1976) Topography of human urokinase activity in renal tissue. Nephron 16: 213–219PubMedCrossRefGoogle Scholar
  11. 11.
    Andrassy K, Koderisch J, Fritz S, Bechtold H, Sonntag H (1986) Alteration of hemostasis associated with cefoperazone treatment. Infection 14: 27–31PubMedCrossRefGoogle Scholar
  12. 12.
    Angles-Cano E, Rondeau E, Delarue F, Hagege J, Sultan Y, Sraer JD (1985) Identification and cellular localization of plasminogen activators from human glomeruli. Thromb Haemost 54: 688–692PubMedGoogle Scholar
  13. 13.
    Arskog D, Aksnes L, Lehman V (1980) Low 1,25 dihydroxyvitamin D in heparininduced osteopenia. Lancet II: 650–651CrossRefGoogle Scholar
  14. 14.
    Atkinson K, Biggs JC, Hayes J, Ralston M, Dodds AJ, Concannon AJ, Naidoo D (1983) Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes. Br J Haematol 54: 59–67PubMedCrossRefGoogle Scholar
  15. 15.
    Avioli L (1975) Heparin induced osteopenia, a reappraisal. Adv Exp Med 52: 375–387Google Scholar
  16. 16.
    Aviram M, Rosenblat M, Potesman M, Dankner G, Brook JG (1986) Plasma lipoprotein and platelet function after heparin injection: studies in normal fasted and postprandial and in type V hyperlipoproteinemic subjects. Biochem Med Metab Biol 35: 279–292PubMedCrossRefGoogle Scholar
  17. 17.
    Bachmann F, Ing TS, Sagartz S (1975) Hyperkoagulabilität und kompensierte intravaskuläre Gerinnung bei chronischer Niereninsuffizienz und nach Nierentransplantation. Schweiz Med Wochenschr 105: 1771–1773PubMedGoogle Scholar
  18. 18.
    Bagdade JD (1980) Accelerated atherosclerosis in patients on maintenance dialysis. Year Book Medical Publishers, Chicago, pp 7–21Google Scholar
  19. 19.
    Barksdale B, Henson EC, Brunson JG (1970) Effects of epinephrine on the generalized Shwartzman reaction. Arch Pathol Lab Med 89: 259–265Google Scholar
  20. 20.
    Barnes AD, Coles GA, White HJO (1974) A controlled trial of anticoagulants in cadaveric renal transplantation. Transplantation 17: 491–494PubMedCrossRefGoogle Scholar
  21. 21.
    Bartheis M, Poliwoda H (1980) Gerinnungsanalysen. Thieme, StuttgartGoogle Scholar
  22. 22.
    Barzu T, Molho P, Tobelem G, Petitou M, Caen JP (1984) Binding of heparin and low molecular weight heparin fragments to human vascular endothelial cells in culture. Nouv Rev Fr Hematol 26: 243–247PubMedGoogle Scholar
  23. 23.
    Baumgartner HR, Tschopp TB (1977) Platelet mediated vasoconstriction: evidence in vivo. Thromb Haemost 38: 186Google Scholar
  24. 24.
    Behring-Werke (1979) Großer Gerinnungsstatus. Behringwerke, Frankfurt am MainGoogle Scholar
  25. 25.
    Bemis J, Rigney J, Sosin A, Deane N (1977) Enhanced platelet aggregation in chronic renal failure patients receiving hemodialysis treatment. Trans Am Soc Artif Intern Organs 23: 48–51PubMedGoogle Scholar
  26. 26.
    Bengtsson G, Olivecrona R, Hok M, Riesenfeld J, Lindahl U (1980) Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides. Biochem J 189: 625–633PubMedGoogle Scholar
  27. 27.
    Bennett NB, Ogston D (1970) Inhibitors of the fibrinolytic enzyme system in renal disease. Clin Sei 39: 549–557Google Scholar
  28. 28.
    Bennett NB, Ogston D, Crawford GPM, Douglas AS (1973) The fibrinolytic enzyme system in hypertension. J Clin Pathol 26: 351–353PubMedCrossRefGoogle Scholar
  29. 29.
    Bennett NM, Bennett D, Holland NH, Luke RG (1972) Serum fibrin degradation products in the diagnosis of transplantation rejection. Transplantation 14: 311–316PubMedCrossRefGoogle Scholar
  30. 30.
    Bergquist D, Bergentz SE, Bornmyr S, Husberg B, Konrad P, Ljungner H (1985) Deep vein thrombosis after renal transplantation: a prospective analysis of frequency and risk factors. Eur Surg Res 17: 69–74CrossRefGoogle Scholar
  31. 31.
    Bergstein JM, Michael AF (1972) Cortical fibrinolytic activity in normal and diseased human kidneys. J Lab Clin Med 79: 701–709PubMedGoogle Scholar
  32. 32.
    Bergstein JM, Hoyer JR, Michael AF (1974) Glomerular fibrinolytic activity following endotoxin-induced glomerular fibrin deposition in the pregnant rat. Am J Pathol 75: 195–199PubMedGoogle Scholar
  33. 33.
    Berkada B, Akokan, G, Derman U (1971) Fibrinolytic response to physical exercise in males. Atherosclerosis 13: 85–91CrossRefGoogle Scholar
  34. 34.
    Bernik MB (1973) Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition. J Clin Invest 52: 823–834PubMedCrossRefGoogle Scholar
  35. 35.
    Bernik MB, Kwaan HC (1969) Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study. J Clin Invest 48: 1740–1753PubMedCrossRefGoogle Scholar
  36. 36.
    Bertele V, Roncaglioni ML, Donati MB, de Gaetano G (1983) Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation. Thromb Haemost 49: 81–83PubMedGoogle Scholar
  37. 37.
    Bick RL, Diekes ML, Wilson WL, Fekete LF (1977) Antithrombin III (AT III) as a diagnostic aid in disseminated intravascular coagulation. Thromb Res 10: 721–729PubMedCrossRefGoogle Scholar
  38. 38.
    Binnema DJ, Iersel JJL van, Dooijewaard G (1986) Quantification of urokinase antigen in plasma and culture media by use of an elisa. Thromb Res 43: 569–577PubMedCrossRefGoogle Scholar
  39. 39.
    Blarney RW, Renney JTG, Baxter TY, Deans BJ (1973) The use of 125J-fibrinogen in the detection of renal allograft rejection. Transplantation 16: 5–8CrossRefGoogle Scholar
  40. 40.
    Blauhut B, Kramar H, Vinazzer H, Bergmann H (1985) Substitution of antithrombin III in shock and DIC: a randomized study. Thromb Res 39: 81–89PubMedCrossRefGoogle Scholar
  41. 41.
    Bleyl U, Kuhn W, Graeff H (1969) Retikuloendotheliale Clearance intravasaler Fibrinmonomere in der Milz. Thromb Diath Haemorrh 22: 87–100PubMedGoogle Scholar
  42. 42.
    Boehmig HJ, Giles GR, Amemiya H et al. (1971) Hyperacute rejection of renal homografts: with particular reference to coagulation changes, humoral antibodies and formed blood elements. Transplant Proc 3: 1105–1116PubMedGoogle Scholar
  43. 43.
    Böhmig HJ (1971) Untersuchungen zur Pathogenese der hyperakuten Abstoßung von Homo- und Heterotransplantaten der Niere beim Hund. Wien Klin Wochenschr 24: 429–436Google Scholar
  44. 44.
    Boneu B, Durand D, Counillon F, Charlet JP, Bierme R, Sue JM (1978) Increased level of factor VIII complex in severe arterial hypertension. Haemostasis 7: 332–338PubMedGoogle Scholar
  45. 45.
    Bonser RS, Adu D, Franklin I, McMaster P (1984) Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient. Lancet II: 1337CrossRefGoogle Scholar
  46. 46.
    Brandt P, Jespersen J, Sorensen LH (1981) Antithrombin III and platelets in haemodialysis patients. Nephron 28: 1–3PubMedCrossRefGoogle Scholar
  47. 47.
    Breddin HK (1986) Akute und chronische Verbrauchskoagulopathie und Nierenerkrankungen. Nieren Hochdruckkr 15: 344–349Google Scholar
  48. 48.
    Brennan TG, Giles GR, Rajah SM, Davison AM, Guillou PJ (1977) Coagulation changes in sensitized canine renal allografts. Br J Surg 64: 15–22PubMedCrossRefGoogle Scholar
  49. 49.
    Brown JE, Baugh RF, Hougie C (1979) Effect of exercise on the factor VIII complex: a correlation of the von Willebrand antigen and factor VIII coagulant antigen increase. Thromb Res 15: 61–67PubMedCrossRefGoogle Scholar
  50. 50.
    Brown PM, Johnston KW, Fenton SSA, Cattran DC (1981) Symptomatic exacerbation of peripheral vascular disease with chronic ambulatory peritoneal dialysis. Clin Nephrol 16: 258–261PubMedGoogle Scholar
  51. 51.
    Brown Z, Neild GH, Willoughby JJ, Somia NV, Cameron SJ (1986) Increased factor VIII as an index of vascular injury in cyclosporine nephrotoxicity. Transplantation 42: 150–153PubMedCrossRefGoogle Scholar
  52. 52.
    Broyer M, Brunner FP, Brynger H et al.(1982) Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc Eur Ren Assoc 19: 2–59Google Scholar
  53. 53.
    Broze GJ Jr (1982) Binding of human factor VII and Vila to monocytes. J Clin Invest 70: 526–535PubMedCrossRefGoogle Scholar
  54. 54.
    Buluk K, Furman M (1962) On the controlling function of the kidneys in fibrinolysis. Experientia 18: 146–147PubMedCrossRefGoogle Scholar
  55. 55.
    Busch GJ, Martins ACP, Hollenberg NK, Wilson RW, Colman RW (1975) A primate model of hyperacute renal allograft rejection. Am J Pathol 79: 31–56PubMedGoogle Scholar
  56. 56.
    Busch GJ, Kobayashi K, Hollenberg NK, Birtch AG, Colman RW (1975) Hyperacute renal allograft rejection in the primate. Am J Pathol 80: 1–19PubMedGoogle Scholar
  57. 57.
    Busch GJ, Martins ACP, Hollenberg NK, Moretz RC, Wilson RE, Colman RW (1976) Successful short-term modification of hyperacute renal allograft rejection in the primate. Am J Pathol 82: 43–60PubMedGoogle Scholar
  58. 58.
    Cade JF, Buchanan MR, Boneu B, Ockelford P, Carter CJ, Cerskus AL, Hirsh J (1984) A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation. Thromb Res 35: 613–625PubMedCrossRefGoogle Scholar
  59. 59.
    Camussi G (1986) Potential role of platelet-activating factor in renal pathophysiology. Kidney Int 29: 469–477PubMedCrossRefGoogle Scholar
  60. 60.
    Canavese C, Stratta P, Pacitti A et al. (1982) Impaired fibrinolysis in uremia: partial and variable correction by four different dialysis regimes. Clin Nephrol 17: 82–89PubMedGoogle Scholar
  61. 61.
    Capitanio A, Mannucci PM, Ponticelli C, Pareti F (1982) Detection of circulating released platelets after renal transplantation. Transplantation 33: 298–301PubMedCrossRefGoogle Scholar
  62. 62.
    Carlsen E, Courillon-Mallet A, Prydz H (1985) Effect of cyclosporin A on procoagulant activity in mononuclear blood cells and monocytes in vitro. Clin Exp Immunol 60: 407–416PubMedGoogle Scholar
  63. 63.
    Carter CJ, Kelton JG, Hirsh J, Gent M (1981) Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin. Thromb Res 21: 169–174PubMedCrossRefGoogle Scholar
  64. 64.
    Carter CJ, Kelton JG, Hirsh J, Santos AV, Gent M (1982) The relationship between the hemorrhagic and antithrombotic properties of the low molecular weight heparin in rabbits. Blood 59: 1239–1245PubMedGoogle Scholar
  65. 65.
    Carvalho AC A (1983) Bleeding in uremia-a clinical challenge. N Engl J Med 308: 38–39PubMedCrossRefGoogle Scholar
  66. 66.
    Carvalho JS, Carvalho ACA, Vaillancourt RA, Page LB, Colman RW, Landwehr DM, Oken DE (1978) The pathogenetic significance of intravascular coagulation in experimental acute renal failure. Nephron 22: 484–491PubMedCrossRefGoogle Scholar
  67. 67.
    Cash JD, Woodfield DG (1968) Fibrinolytic response to moderate exercise in 50 healthy middle-aged subjects. Br Med J II: 658–661CrossRefGoogle Scholar
  68. 68.
    Cash JD, Woodfield DG, Allan AGE (1970) Adrenergic mechanisms in the systemic plasminogen activator response to adrenaline in man. Br J Haematol 18: 487–494PubMedCrossRefGoogle Scholar
  69. 69.
    Castaldi PA, Rozenberg MC, Stewart JH (1966) The bleeding disorder of uraemia: a qualitative platelet defect. Lancet II: 66–69CrossRefGoogle Scholar
  70. 70.
    Charytan C, Purtilo D (1969) Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med 280: 1102–1104PubMedCrossRefGoogle Scholar
  71. 71.
    Cheney K, Bonnin JA (1962) Haemorrhage, platelet dysfunction and other coagulation defects in uraemia. Br J Haematol 8: 215–222PubMedCrossRefGoogle Scholar
  72. 72.
    Cheung AK, Henderson LW (1986) Effects of complement activation by hemodialysis membranes. Am J Nephrol 6: 81–91PubMedCrossRefGoogle Scholar
  73. 73.
    Clark J, Hochman R, Rolla AR, Thomas S, Miller DG, Kaldany A, Délia JA (1983) Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure. Clin Exp Dial Apher 7: 177–190Google Scholar
  74. 74.
    Clarkson AR, MacDonald MK, Fuster V, Cash JD, Robson JS (1970) Glomerular coagulation in acute ischaemic renal failure. Q J Med 39: 585–599PubMedGoogle Scholar
  75. 75.
    Clarkson AR, Morton JB, Cash JD (1970) Urinary ftbrin/fibrinogen degradation products after renal homotransplantation. Lancet II: 1220–1225CrossRefGoogle Scholar
  76. 76.
    Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17: 237–246PubMedCrossRefGoogle Scholar
  77. 77.
    Clyne DH, Kincaid-Smith P, Ribush NT, Morris PJ, Marshall VC (1970) Improvement in renal blood flow of rejecting renal allografts during heparin infusion. Med J Aust 1:522–524Google Scholar
  78. 78.
    Cochran M, Lawton S, Rowlands LM (1979) Fibrinous pericaditis and fibrinolysis in chronic dialysis patients. Clin Nephrol 11: 23–25PubMedGoogle Scholar
  79. 79.
    Cohen BD, Patel H, Kornhauser RS (1977) Alternate reasons for atherogenesis in uremia. Proc Dial Transplant Forum 7: 178–180Google Scholar
  80. 80.
    Cole EH, Cardella CJ, Schulman J, Levy GA (1985) Monocyte procoagulant in activity and plasminogen activator. Transplantation 40: 363–371PubMedCrossRefGoogle Scholar
  81. 81.
    Collen D (1980) Natural inhibitors of fibrinolysis. J Clin Pathol [Suppl 14] 33: 24–30CrossRefGoogle Scholar
  82. 82.
    Collen D, Lijnen HR (1986) The fibrinolytic system in man. CRC Crit Rev Oncol Hematol 4: 249–301CrossRefGoogle Scholar
  83. 83.
    Collen D, Schetz J, De Cock F, Holmer E, Verstraete M (1977) Metabolism of antithrombin III in man: effects of venous thrombosis and of heparin administration. Eur J Clin Invest 7: 27–35PubMedCrossRefGoogle Scholar
  84. 84.
    Colman RW (1984) Surface-mediated defense reactions. The plasma contact activation system. J Clin Invest 73: 1249–1253PubMedCrossRefGoogle Scholar
  85. 85.
    Colman RW, Schmaier AH (1986) The contact activation system: biochemistry and interactions of these surface-mediated defense reactions. CRC Crit Rev Oncol Hematol 5: 57–85CrossRefGoogle Scholar
  86. 86.
    Colman RW, Wong PY (1977) Participation of hageman factor dependent pathways in human disease states. Thromb Haemost 38: 751–775PubMedGoogle Scholar
  87. 87.
    Colman RW, Braun WE, Busch GJ, Dammin GJ, Merrill JP (1969) Coagulation studies in the hyperacute and other forms of renal-allograft rejection. N Engl J Med 281:685–691PubMedCrossRefGoogle Scholar
  88. 88.
    Colman RW, Habal M, Hollenberg NK, Birtch AG, Busch GJ (1976) Hyperacute renal allograft rejection in the primate. Am J Pathol 82: 25–42PubMedGoogle Scholar
  89. 89.
    Colwell JA (1986) Effects of exercise on platelet function, coagulation, and fibrinolysis. Diab Metab Rev 1: 501–512CrossRefGoogle Scholar
  90. 90.
    Corda R, Alberti M, Cacocci L, Putzolu G, Mannucci PM (1979) An increased factor VHI-antigen as an indicator of endothelial damage in measles. Thromb Res 14:805–810PubMedCrossRefGoogle Scholar
  91. 91.
    Cosgriff SW (1951) Thromboembolic complications associated with ACTH and cortisone therapy. JAMA 147: 924–926Google Scholar
  92. 92.
    Crawford GA, Sardie E, Stewart JH (1979) Heparin-released plasma lipases in chronic renal failure and after renal transplantation. Clin Sei 57: 155–165Google Scholar
  93. 93.
    Crisnic I, Cucuianu M, Manasia M, Uza G (1971) Disseminated intravascular coagulation and acute renal failure. Thromb Diath Haemorrh 26: 332–340PubMedGoogle Scholar
  94. 94.
    Date A, Pulimood R, Jakob CK, Kirubakaran MG, Shastry JCM (1986) Haemolytic-uraemic syndrome complicating snake bite. Nephron 42: 89–90PubMedCrossRefGoogle Scholar
  95. 95.
    Davies JWL, Liljedahl S-O, Reizenstein P (1970) Fibrinogen metabolism following injury and its surgical treatment. Injury 1:178–185CrossRefGoogle Scholar
  96. 96.
    Davis GL, Abildgaard CF, Bernauer EM, Britton M (1976) Fibrinolytic and haemostatic changes during and after maximal exercise in males. J Appl Physiol 40: 287–291PubMedGoogle Scholar
  97. 97.
    Delvos U, Müller-Berghaus G (1985) Die Bedeutung des Endothels der Gefäßwand für die Aufrechterhaltung der Hämostase. Klin Wochenschr 63:1237–1246PubMedCrossRefGoogle Scholar
  98. 98.
    Denson KWE (1977) The ratio of factor Vlll-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting. Thromb Res 10: 107–119PubMedCrossRefGoogle Scholar
  99. 99.
    Deykin D (1983) Uremic bleeding. Kidney Int 24: 698–705PubMedCrossRefGoogle Scholar
  100. 100.
    Diehm C, Moerl H, Schettler G (1984) Beeinflussung von Blutgerinnung und Fibrinolyse durch körperliche Aktivität. Klin Wochenschr 62: 299–302PubMedCrossRefGoogle Scholar
  101. 101.
    Docci D, Turci F, Del Vecchio C, Bilancioni R, Cenciotti L, Pretolani E (1984) Hemodialysis - associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry. Int J Artif Organs 7: 337–340PubMedGoogle Scholar
  102. 102.
    Dooijewaard G, Tersel JJL van, Los P, Kluft C (1983) The intrinsic system of fibrinolysis: identification and partial purification of plasma urokinase. In: Davidson JF, Bachmann F, Bouvier CA, Kruithof EO (eds) Progress in fibrinolysis VI. Churchill Livingstone, Edinburgh London Melbourne New York, pp 46–49Google Scholar
  103. 103.
    Drannik GN, Yena YM (1979) Hemocoagulation disorders in kidney allotrans-plants, caused by preformed antirenal antibodies. Thromb Res 16: 527–536PubMedCrossRefGoogle Scholar
  104. 104.
    Drommer R, Merten HA, Stankovic P, Köstering H (1984) Instillation von Heparin-Antithrombin III-Lösungen zur Verbesserung der Transplantationserfolge bei mikrovaskulär anastomisierten Unterarmlappen. In: Köstering H (Hrsg) Antithrombin III. Schattauer, Stuttgart S 185–190Google Scholar
  105. 105.
    Drukker W (1978) Haemodialysis: A historical review. In: Drukker W, Parsons M, Mäher JF (eds) Replacement of renal function by dialysis. Nijhoff, Dordrecht, pp 3–37Google Scholar
  106. 106.
    Dunn FW, Soria C, Thomaidis A, Soria J, Dupuy E, Bellucci S, Tobelem G (1984) Interaction of platelets with standard heparin and low molecular weight fractions. Nouv Rev Fr Hematol 26: 249–253PubMedGoogle Scholar
  107. 107.
    Dyck RF, Kappell JE, Sheridan D, Card RT (1986) Reversible cyclosporine-associated hemolytic uremic syndrome in a renal transplant recipient: a role for a platelet aggregating factor? Transplant Proc 18: 228–229Google Scholar
  108. 108.
    Edward N (1973) Fibrinolysis in patients on regular hemodialysis. Clin Nephrol 1: 97–100Google Scholar
  109. 109.
    Egbring R (1984) Erworbene Gerinnungsstörungen bei Patienten mit internistischen Erkrankungen. Med Welt 35: 1433–1437Google Scholar
  110. 110.
    Egbring R, Seitz R, Burghard R, Wolf M (1987) Gerinnungsstörungen bei Infektionen und Sepsis. In: Mammen EF (Hrsg) Intensivmedizin aktuell. Medizinische Verlagsgesellschaft, Marburg, S 81–98Google Scholar
  111. 111.
    Eika C (1972) On the mechanism of platelet aggregation induced by heparin, protamine, and polybrene. Scand J Haematol 9: 248–257PubMedCrossRefGoogle Scholar
  112. 112.
    Eknoyan G, Wacksman SJ, Glueck HJ, Will JJ (1969) Platelet function in renal failure. N Engl J Med 280: 677–681PubMedCrossRefGoogle Scholar
  113. 113.
    Erickson LA, Schleef RR, Ny T, Loskutoff DJ (1985) The fibrinolytic system of the vascular wall. Clin Haematol 14: 513–530PubMedGoogle Scholar
  114. 114.
    Erickson RV, Williman M, Pendras JP (1966) A true hypercoagulability state in patients on chronic hemodialysis. Trans Am Soc Artif Intern Organs 12: 205–206PubMedGoogle Scholar
  115. 115.
    Everett MM, Emerson TE (1984) Antithrombin III (ATIII) increase survival and diseases mortality during endotoxin shock in the rat. Circ Shock 13: 29Google Scholar
  116. 116.
    Ferguson EW, Guest NM (1974) Exercise, physical conditioning, blood coagulation and fibrinolysis. Thromb Diath Haemorrh 31: 63–71PubMedGoogle Scholar
  117. 117.
    Forbes CD (1981) Thrombosis and artificial surfaces. Clin Haematol 10: 653–668PubMedGoogle Scholar
  118. 118.
    Forbes CD, Pensky J, Ratnoff OD (1970) Inhibition of activated hageman factor and activated plasma thromboplastin antecedent by purified serum CI inactivator. J Lab Clin Med 76: 809–815PubMedGoogle Scholar
  119. 119.
    Frampton G, Parbtani A, Marchesi D, Duffus P, Livio M, Remuzzi G, Cameron JS (1983) In vivo platelet activation with in vitro hyperaggregability to arachidonic acid in renal allograft recipients. Kidney Int 23: 506–513PubMedCrossRefGoogle Scholar
  120. 120.
    Friberger P (1982) Chromogenic peptide substrates. Scand J Clin Lab Invest [Suppl 162] 42: 1–298CrossRefGoogle Scholar
  121. 121.
    Friberger P, Gallimore MJ (1986) Activation of fibrinolysis. In: Köstering H, Kreuzer H, Neuhaus KL (Hrsg) Thrombolytische Therapie des akuten Myokardinfarktes. Schattauer, Stuttgart, S 21–26Google Scholar
  122. 122.
    Fuchs U, Graff J (1986) Gefaßwand und Fibrinolyse. Pathologische Aspekte. Folia Haematol 113: 176–183Google Scholar
  123. 123.
    Fuster V, Bowie EJW, Lewis JC, Fass DN, Owen CI Jr, Brown AL (1978) Resistance to arteriosclerosis in pigs with von Willebrand disease. J Clin Invest 61: 722–730PubMedCrossRefGoogle Scholar
  124. 124.
    Gader AMA, Clarkson AR, Cash JD (1973) The plasminogen activator and coagulation factor VIII responses to adrenaline, noradrenaline, isoprenaline and salbutamol in man. Thromb Res 2: 9–16CrossRefGoogle Scholar
  125. 125.
    Gader AMA, da Costa J, Cash JD (1974) The effect of propanolol, and practolol on the fibrinolytic and factor VIII responses to adrenaline and salbutamol in man. Thromb Res 4: 25–33PubMedCrossRefGoogle Scholar
  126. 126.
    Gallimore MJ (1984) Das Plasma-Kallikrein-Kinin-System und Antithrombin III. In: Köstering H (Hrsg) Antithrombin III. Schattauer, Stuttgart, S 17–26Google Scholar
  127. 127.
    Gallimore MJ (1985) Chromogenic peptide substrate assays for determining components of the plasma kallikrein system. Scand J Clin Lab Invest [Suppl 178] 45: 127–132Google Scholar
  128. 128.
    Gallimore MJ, Friberger P (1982) Simple chromogenic substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein,like‘ activity in human plasma. Thromb Res 25: 293–298PubMedCrossRefGoogle Scholar
  129. 129.
    Gallimore MJ, Aasen AO, Smith-Erichsen N, Larsbraaten M, Lyngaas K, Amundsen E (1980) Plasminogen concentrations and functional activities and concentrations of plasmin inhibitors in plasma samples from normal subjects and patients with septic shock. Thromb Res 18: 601–608PubMedCrossRefGoogle Scholar
  130. 130.
    Gavras H, Oliver N, Aitchison J et al. (1975) Abnormalities of coagulation and the development of malignant phase hypertension. Kidney Int 8: 252–261Google Scholar
  131. 131.
    George CRP, Slichter SJ, Quadracci U, Striker GE, Harker LA (1974) A kinetic evaluation of hemostasis in renal disease. N Engl J Med 291: 1111–1115PubMedCrossRefGoogle Scholar
  132. 132.
    George CRP, Slichter SJ, Quadracci LJ, Kenny GM, Dennis MB, Striker GE, Harker LA (1975) The treatment of rejection. A trial of acetylsalicylic acid, dipyridamole, and heparin. Transplantation 20: 237–240PubMedCrossRefGoogle Scholar
  133. 133.
    Gilboa N, Erdman J, Urizar RE (1982) Quantitative spectrophotometric assay of renal tissue plasminogen activator. Kidney Int 22: 80–83PubMedCrossRefGoogle Scholar
  134. 134.
    Girndt J, Scheler F, Bohle A (1978) Blutgerinnungsstörungen, ein pathogenetischer Faktor für Nephrosklerose und Hochdruck. Dtsch Med Wochenschr 5: 199–204CrossRefGoogle Scholar
  135. 135.
    Giroux L, Boury F, Smeesters C, Corman J, Daloze PM (1981) Modifications of glomerular fibrinolysis in human renal graft rejection. J Surg Res 31: 253–258PubMedCrossRefGoogle Scholar
  136. 136.
    Godal HC, Abildgaard U, Kierulf P (1971) Ethanol gelation and fibrin monomers in plasma. Scand J Haematol 13: 189–191Google Scholar
  137. 137.
    Goldstein MH (1979) Hemolytic-uremic syndrome. Nephron 23: 263–272PubMedCrossRefGoogle Scholar
  138. 138.
    Gralnick HR, Marchesi S, Givelber H (1972) Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities. Blood 40: 709–718PubMedGoogle Scholar
  139. 139.
    Griffin JH, Cochrane CG (1979) Recent advances in the understanding of contact activation reactions. Semin Thromb Hemost 5: 254–273PubMedGoogle Scholar
  140. 140.
    Griffin PJA, Salaman JR (1981) A controlled trial of heparin in renal transplant rejection. Transplantation 32: 306–307PubMedCrossRefGoogle Scholar
  141. 141.
    Grino JM, Alsina J, Martin J, Roca M, Castelao A, Romero R, Caralps A (1982) Indium-Ill labeled autologous platelets as a diagnostic method in kidney allograft rejection. Transplant Proc 14: 198–200Google Scholar
  142. 142.
    Grünfeld JP, Ganeval D, Bournerias F (1980) Acute renal failure in pregnancy. Kidney Int 18: 179–191PubMedCrossRefGoogle Scholar
  143. 143.
    Gunnarsson B, Asaba H, Dawidson S, Wilhelmsson S, Bergström J (1981) The effects of three different heparin regimes on heparin concentration in plasma and fibrin formation in dialyzers. Clin Nephrol 15: 135–142PubMedGoogle Scholar
  144. 144.
    Gurewich V, Lipinski B (1976) Semiquantitative determination of soluble fibrin monomer complexes by chromatography and serial-dilution protamine sulfate test. Am J Clin Pathol 65: 397–401PubMedGoogle Scholar
  145. 145.
    Haas G (1926) Über Versuche der Blutauswaschung am Lebenden mit Hilfe der Dialyse. Naunyn Schmiedebergs Arch Pharmacol 116: 158–172Google Scholar
  146. 146.
    Haas G (1927) Versuche mit Blutauswaschung am Lebenden mit der Hilfe der Dialyse. Naunyn Schmiedebergs Arch Pharmacol 120: 371–386Google Scholar
  147. 147.
    Haberland GL (1978) The role of kininogenases, kinin formation and kininogenase inhibition in post traumatic shock and related conditions. Klin Wochenschr 56: 325–331PubMedCrossRefGoogle Scholar
  148. 148.
    Hakim RM, Schafer AI (1985) Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med 78: 575–580PubMedCrossRefGoogle Scholar
  149. 149.
    Hakim RM, Fearon DT, Lazarus JM (1984) Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 26: 94–100CrossRefGoogle Scholar
  150. 150.
    Hall CL, Nooshabeh P, Thomson RW et al.(1973) Serial estimation of urinary fibrin/fibrinogen degradation products in kidney transplantation. Br Med J 3: 204–207PubMedCrossRefGoogle Scholar
  151. 151.
    Halloran PF, Aprile M, Haddad G, Robinette M (1982) The significance of elevated procoagulant activity in the monocytes of renal transplant recipients. Transplant Proc 14: 669–672PubMedGoogle Scholar
  152. 152.
    Halloran PF, Aprile MA, Haddad GJ, Robinette MA (1985) Procoagulant activity in renal transplant recipients. Transplantation 39: 374–377PubMedCrossRefGoogle Scholar
  153. 153.
    Hamsten A, Wiman B, De Faire U, Blombäck M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313: 1557PubMedCrossRefGoogle Scholar
  154. 154.
    Harter R, Burch JW, Majerus PW, Stanford N, Delmez JA, Anderson CB, Weerts CA (1979) Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 301: 577–579PubMedCrossRefGoogle Scholar
  155. 155.
    Hattler BG, Rocklin RE, Ward PA, Rickles FR (1973) Functional features of lymphocytes recovered from a human allograft. Cell Immunol 9: 289–295PubMedCrossRefGoogle Scholar
  156. 156.
    Haupt H, Bachmann HJ, Tache E (1974) Urokinaseausscheidung bei Verbrauchskoagulopathie und akutem Nierenversagen. Monatsschr Kinderheilkd 122: 622–623Google Scholar
  157. 157.
    Hawkey CM, Britton BJ, Wood WG, Peele M, Irving MH (1975) Changes in blood catecholamine levels and blood coagulation and fibrinolytic activity in response to graded exercise in man. Br J Haematol 29: 377–384PubMedCrossRefGoogle Scholar
  158. 158.
    Hayasaka T, Yoshiki T, Shiral T, Ninomura N, Ithoh T (1981) Comparative immunopathologic studies of thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome and disseminated intravascular coagulation. Acta Pathol Jpn 31: 569–581PubMedGoogle Scholar
  159. 159.
    Hayslett JP (1985) Postpartum renal failure. N Engl J Med 312: 1556–1559PubMedCrossRefGoogle Scholar
  160. 160.
    Hedner U, Nilsson IM (1971) Urokinase inhibitors in serum in a clinical series. Acta Med Scand 189: 185–189PubMedCrossRefGoogle Scholar
  161. 161.
    Hedner U, Nilsson IM (1971) Clinical experience with determination fibrinogen degradation products. Acta Med Scand 189: 471–477PubMedCrossRefGoogle Scholar
  162. 162.
    Hedner U, Nilsson IM (1973) Pattern of the activator inhibitor in carcinoma and renal diseases. Scand J Haematol 11: 398–404PubMedCrossRefGoogle Scholar
  163. 163.
    Heene DL (1977) Disseminated intravascular coagulation. Evaluation of therapeutic approaches. Semin Thromb Hemost 3: 291–317Google Scholar
  164. 164.
    Heene DL, Matthias FR (1978) Hämostasestörungen im Schock. Verh Dtsch Ges Pathol 62: 103–111PubMedGoogle Scholar
  165. 165.
    Heene DL, Kirschstein W, Dempfle CE (1984) Shock-induced alterations in hemostasis. Klin Wochenschr [Suppl VII] 64: 14–17Google Scholar
  166. 166.
    Heimark RL, Kurachi K, Fugikawa K, Dawie EW (1980) Surface activation of blood coagulation, fibrinolysis and kinin formation. Nature 286: 456–460PubMedCrossRefGoogle Scholar
  167. 167.
    Heimburger N (1980) Antithrombin III/Biochemische Wirkung. In: Marx R, Thies HA (Hrsg) Kontrolle von Antithrombotika. Roche, Grenzach, S 79–84Google Scholar
  168. 168.
    Hellgren M, Hägnerik K, Robbe H, Björk O, Blombäck M, Eklund J (1983) Severe acquired antithrombin III deficiency in relation to hepatic and renal insufficiency and intrauterine fetal death in late pregnancy. Gynecol Obstet Invest 16: 107–118PubMedCrossRefGoogle Scholar
  169. 169.
    Hellgren M, Javelin L, Hägnevik K, Blombäck M, Meden-Britth G (1984) Antithrombin III concentrate as adjuvant in DIC treatment - a pilot study in 9 severely ill patients. Thromb Res 35: 459–466PubMedCrossRefGoogle Scholar
  170. 170.
    Hickman JA (1971) A study of the metabolism of fibrinogen after surgical operations. Clin Sei 41: 141–152Google Scholar
  171. 171.
    Hiepert LM, Jacques CB (1976) Heparin uptake on endothelium. Artery 2: 26–37Google Scholar
  172. 172.
    Highsmith RF, Kline DL (1971) Kidney: primary source of plasminogen after acute depletion in the cat. Science 174:141–142PubMedCrossRefGoogle Scholar
  173. 173.
    Highsmith RF, Kline DL (1973) Plasminogen restoration by the kidney mediated by a plasma factor. Am J Physiol 225: 1032–1037PubMedGoogle Scholar
  174. 174.
    Hildebrand U, Quellhorst E (1985) Influence of various membranes on the coagulation system during dialysis. Contrib Nephrol 46: 92–101PubMedGoogle Scholar
  175. 175.
    Hiller E, Saal JG, Ostendorf P, Griffiths JW (1977) The procoagulant activity of human granulocytes, lymphocytes and monocytes stimulated by endotoxin. Klin Wochenschr 55: 751–757PubMedCrossRefGoogle Scholar
  176. 176.
    Hirsh J (1981) Blood tests for the diagnosis of venous and arterial thrombosis. Blood 57: 1–8PubMedGoogle Scholar
  177. 177.
    Hirsh J (1984) Heparin induced bleeding. Nouv Rev Fr Hematol 266: 261–266Google Scholar
  178. 178.
    Hogg N (1983) Human monocytes have prothrombin cleaving activity. Clin Exp Immunol 53: 725–739PubMedGoogle Scholar
  179. 179.
    Hoie J (1975) Renal vascular resistance changes following thrombin-induced intravascular coagulation: role of platelet and fibrin emboli. Acta Chir Scand 141: 167–172PubMedGoogle Scholar
  180. 180.
    Hoie J, Schenk WG (1972) Experimental intravascular coagulation: impairment of renal blood flow following thrombin infusion in the dog. J Trauma 12: 302–308PubMedCrossRefGoogle Scholar
  181. 181.
    Holmer E, Lindahl U, Bäckström G, Thunberg L, Sandberg H, Söderström G, Andersson L-O (1980) Anticoagulant activities and effect on platelets of a heparin fragment with high affinity for antithrombin. Thromb Res 18: 861–869PubMedCrossRefGoogle Scholar
  182. 182.
    Holmer E, Mattson C, Nilsson S (1982) Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits. Thromb Res 25:475–485PubMedCrossRefGoogle Scholar
  183. 183.
    Hopper KE, Geczy CL, Davies WA (1981) A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages in vivo. J Immunol 126: 1052–1058PubMedGoogle Scholar
  184. 184.
    Hörl WH, Schäfer RM, Heidland A (1985) Effect of different dialysers on proteinases and proteinase inhibition during hemodialysis. Am J Nephrol 8: 320–326Google Scholar
  185. 185.
    Hörl WH, Steinhauer HB, Schollmeyer P (1985) Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes. Kidney Int 28: 791–796PubMedCrossRefGoogle Scholar
  186. 186.
    Hoyer JR, Michael AF, Hoyer LW (1974) Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases. J Clin Invest 53:1375–1384PubMedCrossRefGoogle Scholar
  187. 187.
    Hoyer LW (1981) The factor VIII complex: structure and function. Blood 58: 1–13PubMedGoogle Scholar
  188. 188.
    Hulme B, Pitcher PM (1973) Rapid latex-screening test for detection of fibrin/fibrinogen degradation products in urine after renal transplantation. Lancet I: 6–8CrossRefGoogle Scholar
  189. 189.
    Huser B, Lämmle B, Tran TH, Oberholzer M, Thiel G, Duckert F (1984) Hämostase-Kriterien bei Nierentransplantatträgern. Schweiz Med Wochenschr 114: 1149–1154PubMedGoogle Scholar
  190. 190.
    Huttunen JK, Pasternack A, Vänttinen T, Ehnholm C, Nikkilä EA (1978) Lipoprotein metabolism in patients with chronic uremia. Acta Med Scand 204: 211–218PubMedCrossRefGoogle Scholar
  191. 191.
    Ibels LS, Reardon MF, Nestel PJ (1976) Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients. J Lab Clin Med 87: 648–658PubMedGoogle Scholar
  192. 192.
    Ingram GIC, Jones RV (1966) The rise in clotting factor VIII induced in man by adrenaline: effect of alpha- and beta-blockers. J Physiol 187: 447–454PubMedGoogle Scholar
  193. 193.
    Ingram GIC, Jones RV, Hershgold EJ, Denson KWE, Perkins JR (1977) Factor VHI-activity and antigen, platelet count and biochemical changes after adrenoceptor stimulation. Br J Haematol 35: 81–99PubMedCrossRefGoogle Scholar
  194. 194.
    Ireland H, Lane DA, Curtis JR (1984) Objective assessment of heparin requirements for hemodialysis in humans. J Lab Clin Med 103: 643–652PubMedGoogle Scholar
  195. 195.
    Isacson S, Nilsson IM (1969) The kidneys and the fibrinolytic activity in the blood. Thromb Diath Haemorrh 22: 211–215PubMedGoogle Scholar
  196. 196.
    Isacson S, Nilsson IM (1972) Defective fibrinolysis in blood and vein walls in recurrent idiopathic venous thrombosis. Acta Chir Scand 138: 313–319PubMedGoogle Scholar
  197. 197.
    Isles C, Lowe GDO, Rankin BM, Forbes CD, Lucie N, Lever AF, Kennedy AC (1984) Abnormal haemostasis and blood viscosity in malignant hypertension. Thromb Haemost 52: 253–255PubMedGoogle Scholar
  198. 198.
    Ito S, Camussi G, Telta C, Milgrom F, Andres G (1984) Hyperacute renal allograft rejection in the rabbit. Lab Invest 51: 148–161PubMedGoogle Scholar
  199. 199.
    Ito T, Niva T, Matsai E (1972) Fibrinolytic activity in renal disease. Clin Chim Acta 36: 145–151PubMedCrossRefGoogle Scholar
  200. 200.
    Ivanovich P, Chenoweth DE, Schmidt R, Klinkmann H, Boxer LA, Jacob HS, Hammerschmidt DE (1983) Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int 22: 758–763CrossRefGoogle Scholar
  201. 201.
    Jaffe EA (1977) Endothelial cells and the biology of factor VIII. N Engl J Med 296: 377–383PubMedCrossRefGoogle Scholar
  202. 202.
    Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D (1980) Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303: 1318–1322PubMedCrossRefGoogle Scholar
  203. 203.
    Januszko T, Furman M, Buluk K (1966) The kidneys and the liver as the organs regulating the fibrinolytic system of the circulating blood. Thromb Diath Haemorrh 15: 554–560PubMedGoogle Scholar
  204. 204.
    Jones FE, Black PJ, Cameron JS et al. (1975) Local infusion of urokinase and heparin into renal arteries in independing renal cortical necrosis. Br Med J 4: 547–549PubMedCrossRefGoogle Scholar
  205. 205.
    Jörgensen M, Eriksen HO, Tranebjoerg L (1985) Plasma antithrombin III concentration in patients on regular haemodialysis treatment. Nephron 40: 22–24PubMedCrossRefGoogle Scholar
  206. 206.
    Jubelirer SJ (1985) Hemostatic abnormalities in renal disease. Am J Kidney Dis 5: 219–225PubMedGoogle Scholar
  207. 207.
    Jurewicz WA, Dykes JGA, Gunson BK, Chandler ST, Hawker RJ, Barnes AD (1984) Indium-Ill-labeled platelets as a diagnostic aid in posttransplant monitoring of renal allografts in humans. Transplant Proc 16: 1481–1483PubMedGoogle Scholar
  208. 208.
    Kadish JL (1979) Fibrin and atherogenesis- a hypothesis. Atherosclerosis 33: 409–413PubMedCrossRefGoogle Scholar
  209. 209.
    Kane K (1984) Fibrinolysis - a review. Ann Clin Lab Sei 14: 443–449Google Scholar
  210. 210.
    Kanfer A (1982) Coagulation and renal diseases. Proc Eur Dial Transplant Assoc Eur Ren Assoc 19: 703–713Google Scholar
  211. 211.
    Kanfer A, Vandewalle A, Beaufils M, Delarue F, Sraer JD (1975) Enhanced antiplasmin activity in acute renal failure. Br Med J 4: 195–197PubMedCrossRefGoogle Scholar
  212. 212.
    Kaplan AP (1978) Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, Hageman factor, prekallikrein, high molecular weight kininogen and factor XI. Prog Heamost Tromb 4: 127–175Google Scholar
  213. 213.
    Kaplan AP, Yecies LD (1980) Initiation of Hageman-factor-dependent fibrinolysis. In: Kline DL, Reddy KNN (eds) Fibrinolysis. CRC Press, Boca Raton, pp 43–69Google Scholar
  214. 214.
    Kaplan JE (1979) Effect of reticuloendothelial blockade on the development of hypertension after trauma, sepsis, and intravascular coagulation. Adv Shock Res 2: 73–81PubMedGoogle Scholar
  215. 215.
    Kaplinsky C, Frand M, Rubinstein ZJ (1980) Disseminated intravascular clotting and renal cortical necrosis complicating a snake bite. Clin Pediatr 19: 229–231CrossRefGoogle Scholar
  216. 216.
    Karges HE, Heimburger N (1984) Grundlagen und Biochemie des Antithrombin III. In: Köstering H (Hrsg) Antithrombin III. Schattauer, Stuttgart, S 7–16Google Scholar
  217. 217.
    Kauffman HM, Ekbom GA, Adams MB, Hussey CV (1979) Hypercoagulability: a cause of vascular access failure. Proc Clin Dial Transplant Forum 9: 28–31PubMedGoogle Scholar
  218. 218.
    Keber D, Stegnar M, Keber I, Accetto B (1979) Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion. Thromb Haemost 41: 745–755PubMedGoogle Scholar
  219. 219.
    Kierulf P, Aasen AO, Aune S, Godal HC, Ruud TE, Vaage J (1982) Chromogenic peptide substrate assays in patients with multiple trauma. Acta Chir Scand [Suppl] 509: 69–72Google Scholar
  220. 220.
    Kincaid-Smith P (1969) Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anti-coagulants. Lancet II: 920–922CrossRefGoogle Scholar
  221. 221.
    Kincaid-Smith P (1970) The pathogenesis of the vascular and glomerular lessions of rejection in renal allografts and their modification by anti-thrombotic and anticoagulant drugs. Aust Ann Med 19: 201–214PubMedGoogle Scholar
  222. 222.
    Kincaid-Smith P (1972) Coagulation and renal disease. Kidney Int 2: 183–190PubMedCrossRefGoogle Scholar
  223. 223.
    Kincaid-Smith P (1973) The role of coagulation in the obliteration of glomerular capillars. Perspect Nephrol Hypertens 2: 871–890Google Scholar
  224. 224.
    Kincaid-Smith P (1975) Participation of intravascular coagulation in the pathogenesis of glomerular and vascular lesions. Kidney Int 7: 242–253PubMedCrossRefGoogle Scholar
  225. 225.
    King DJ, Kelton JG (1984) Heparin-associated thrombocytopenia. Ann Intern Med 100: 535–540PubMedGoogle Scholar
  226. 226.
    Kirchstein W, Heene DL (1985) Fibrinolysis inhibition in acute respiratory distress syndrome. Scand J Clin Lab Invest [Suppl 178] 45: 87–94Google Scholar
  227. 227.
    Kitamura T, Oshi M, Umeda T, Ueno A, Nijima T (1984) Postoperative acute renal and hepatic failure in a case of pheochromocytoma, possibly induced by disseminated intravascular coagulation. Jpn J Nephrol 26: 309–317Google Scholar
  228. 228.
    Kleinknecht D, Verger D, Mignon F, Richet G (1970) Insuffisance renale et pancreatite aigue. Signification des depots fibrinoides intraglomerulaires. Ann Med Interne (Paris) 121: 17–28Google Scholar
  229. 229.
    Kleinknecht D, Jungers P, Clianard J et al. (1972) Uremic and non-uremic complications in acute renal failure. Evaluation of early and frequent dialysis on prognosis. Kidney Int 1: 190–196PubMedCrossRefGoogle Scholar
  230. 230.
    Kleinknecht D, Kanfer A, Josso F (1972) Intravascular coagulation and heparin therapy in acute renal failure: a reappraisal. Rev Eur Etud Clin Biol 17: 695–700PubMedGoogle Scholar
  231. 231.
    Kleinknecht D, Grünfeld JP, Gomez PC, Moreau JF, Garcia-Torres R (1973) Diagnostic procedures and long-term prognosis in bilateral renal cortical necrosis. Kidney Int 4: 390–400PubMedCrossRefGoogle Scholar
  232. 232.
    Kluft C, Wijngaards G, Jie AFH (1981) The factor XII-independant plasminogen proactivator system of plasma includes urokinase-related activity. Thromb Haemost 46: 343Google Scholar
  233. 233.
    Kluft C, Wijngaards G, Jie AFH (1983) Intrinsic plasma fibrinolysis: involvement of urokinase related activity in the factor XII-independent plasminogen proactivator pathway. In: Davidson JF, Bachmann F, Bouvier CA, Kruithof EKO (eds) Progess in fibrinolysis VI. Churchill Livingstone, Edinburgh London New York, pp 43–45Google Scholar
  234. 234.
    Kluft C, Wijngaards G, Jie AFH (1984) Intrinsic plasma fibrinolysis: involvement of UK-related activity in the factor XII-independent plasminogen proactivator pathway. J Lab Clin Med 103: 405–419Google Scholar
  235. 235.
    Knudsen F, Dyerberg J (1985) Platelets and antithrombin III in uraemia: the acute effect of haemodialysis. Scand J Clin Lab Invest 45: 341–347PubMedCrossRefGoogle Scholar
  236. 236.
    Koffler D, Paronetto F (1966) Fibrinogen deposition in acute renal failure. Am J Pathol 49: 383–395PubMedGoogle Scholar
  237. 237.
    Kopitsky RG, Switzer MEP, Sanders Williams R, McKee PA (1983) The basis for the increase in factor VIII procoagulant activity during exercise. Thromb Haemost 49: 53–57PubMedGoogle Scholar
  238. 238.
    Köstering H (1974) Blutungskomplikationen bei Patienten mit terminaler Niereninsuffizienz. Aktuel Nephrol 3: 99–110Google Scholar
  239. 239.
    Köstering H (1981) Die Thromboembolien. Schattauer, StuttgartGoogle Scholar
  240. 240.
    Köstering H (1984) Antithrombin III. Schattauer, StuttgartGoogle Scholar
  241. 241.
    Köstering H, Kreuzer H, Neuhaus KL (1986) Thrombolytische Therapie des akuten Myokardinfarktes. Schattauer, StuttgartGoogle Scholar
  242. 242.
    Kramer P (1985) Arteriovenous hemofiltration. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  243. 243.
    Krug H, Raszeja-Wanic B, Wochowiak A (1974) Intravascular coagulation in acute renal failure after myocardial infarction. Ann Intern Med 81: 494–497PubMedGoogle Scholar
  244. 244.
    Kucinsky CS, Fletcher AP, Sherry S (1968) Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase. J Clin Invest 47: 1238–1253CrossRefGoogle Scholar
  245. 245.
    Kuhlbäck B (1957) Bleeding tendency in chronic renal failure. Acta Med Scand 157: 173–177PubMedCrossRefGoogle Scholar
  246. 246.
    Kwaan HC (1979) Physiologic and pharmacologic implications of fibrinolysis. Artery 5: 285–290PubMedGoogle Scholar
  247. 247.
    Kwaan HC (1984) The role of fibrinolysis in disease processes. Semin Thromb Hemost 10: 71–79PubMedCrossRefGoogle Scholar
  248. 248.
    Kwaan HC, Anderson MC, Gramatica L (1971) A study of pancreatic enzymes as a factor in the pathogenesis of disseminated intravascular coagulation during acute pancreatitis. Surgery 69: 663–672PubMedGoogle Scholar
  249. 249.
    Lämmle E, Tran TH, Ritz R, Duchert F (1984) Plasma prekallikrein, factor XII, antithrombin III, C 1-inhibitor and alpha2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). Am J Pathol 82: 396–404Google Scholar
  250. 250.
    Larsson LI, Skeriver L, Nielsen LS, Grondall-Hansen J, Kristensen P, Dano K (1984) Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. J Cell Biol 98: 894–903PubMedCrossRefGoogle Scholar
  251. 251.
    Larsson SO (1971) On coagulation and fibrinolysis in uraemic patients on maintenance haemodialysis. Acta Med Scand 189: 453–462PubMedCrossRefGoogle Scholar
  252. 252.
    Larsson SO, Hedner U, Nilsson IM (1971) On coagulation and fibrinolysis in acute renal insufficiency. Acta Med Scand 189: 443–451PubMedCrossRefGoogle Scholar
  253. 253.
    Lasch HG (1975) Verbrauchskoagulopathie-Ursache und Folge von Blutungen. Med Welt 26: 697–703PubMedGoogle Scholar
  254. 254.
    Lasch HG, Schütterle G (1970) Niere und Hämostase. Klin Wochenschr 48: 1019–1024PubMedCrossRefGoogle Scholar
  255. 255.
    Lazarus JM (1980) Complications in hemodialysis: an overview. Kidney Int 18: 783–796CrossRefGoogle Scholar
  256. 256.
    Lee L, House PH, Cohen MH (1966) The role of the reticuloendothelial system in diffuse low grade intravascular coagulation. In: Brinkhouse K, Wright JS, Koller F, Strauli E, Duckert F (eds) Diffuse intravascular clotting. Schattauer, Stuttgart, pp 87–95Google Scholar
  257. 257.
    Leithner S, Sinzinger H, Schwarz M (1981) Treatment of chronic kidney transplant rejection with prostacyclin - reduction of platelet deposition in the transplant: prolongation of platelet survival and improvement of transplant function. Prostaglandins 22: 783–788PubMedCrossRefGoogle Scholar
  258. 258.
    Leithner S, Sinzinger H, Pohanka I, Schwarz M, Kretschmer G, Syre G (1983) Occurrence of haemolytic uraemic syndrome under cyclosporine treatment: accident or possible side effect mediated by a lack of prostacyclin-stimulating plasma factor. Transplant Proc 15: 2787–2789Google Scholar
  259. 259.
    Lewis JH, Zucker MB, Ferguson JH (1956) Bleeding tendency in uremia. Blood 11: 1073–1076PubMedGoogle Scholar
  260. 260.
    Lian ECY, Nunez RL, Harkness DR (1976) In vivo and in vitro effects of thrombin and plasmin on human factor VIII (AHF). Am J Hematol 1: 481–491PubMedCrossRefGoogle Scholar
  261. 261.
    Liehr H (1982) Die Bedeutung der Leber und des RES im Schock. Hämostaseologie 2: 68–72Google Scholar
  262. 262.
    Lijnen HR, Collen D, Verstraete M (1980) Synthetic substrates in clinical blood coagulation assays. Nijhoff, The Hague Boston LondonCrossRefGoogle Scholar
  263. 263.
    Lindner A, Charra D, Sherrard DF, Scribner BH (1974) Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697–701PubMedCrossRefGoogle Scholar
  264. 264.
    Lindquist RR, Guttmann RD, Merrill JP, Dammin GJ (1968) Human renal allografts: interpretation of morphologic and immunohistochemical observations. Am J Pathol 5: 851–881Google Scholar
  265. 265.
    Lindsay RM, Moorthey AV, Koens F, Linton AL (1975) Platelet function in dialyzed and non dialyzed patients with chronic renal failure. Clin Nephrol 4: 52–57PubMedGoogle Scholar
  266. 266.
    Lindsay RM, Friesen M, Koens F, Linton AL, Oreopoulos D, De Yeber G (1976) Platelet function in patients on long term peritoneal dialysis. Clin Nephrol 6: 335–339PubMedGoogle Scholar
  267. 267.
    Lipinski B, Worowski K (1968) Detection of soluble fibrin monomer complexes by means of protamine-sulfate-test. Thromb Diath Haemorrh 20: 44–49PubMedGoogle Scholar
  268. 268.
    Llach F (1985) Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int 28: 429–439PubMedCrossRefGoogle Scholar
  269. 269.
    Losman JG, Rose AG, Barnard CN (1977) Myocardial fibrinolytic activity in allogenic cardiac rejection. Transplantation 23: 414–422PubMedCrossRefGoogle Scholar
  270. 270.
    Losonczy G (1984) Intrarenal blood coagulation induced by ischemia in rats. Heparin and thrombozytopenia does not prevent the intracortical fibrin formation. Thromb Res 34: 87–92PubMedCrossRefGoogle Scholar
  271. 271.
    Losonczy G, Harsing L (1982) Simultaneous activation of coagulation and fibrinolysis after severe renal ischemia in rats. Nephron 32: 180–184PubMedCrossRefGoogle Scholar
  272. 272.
    Losowsky MS, Walls WD (1971) Abnormalities of haemostasis in renal failure. J R Coll Physicians Lond 5: 148–156PubMedGoogle Scholar
  273. 273.
    Lowenhaupt R, Nathan P (1968) Platelet accumulation observed by electron microscopy in the early phase of renal allotransplant rejection. Nature 220: 822–825PubMedCrossRefGoogle Scholar
  274. 274.
    Lüscher EF (1982) The role of blood cells and of the vessel wall in the induction of intravascular coagulation. Klin Wochenschr 60: 710–712PubMedCrossRefGoogle Scholar
  275. 275.
    Lyberg T (1984) Clinical significance of increased thromboplastin activity on the monocyte surface-a brief review. Haemostasis 14: 430–439PubMedGoogle Scholar
  276. 276.
    MacDonald AS, Busch GJ, Alexander JL, Pheteplace EA, Menzoian J, Murray JE (1970) Heparin and aspirin in the treatment of renal allografts in presensitized dogs. Transplantation 9:1–7PubMedCrossRefGoogle Scholar
  277. 277.
    MacDonald AS, Bell WR, Busch GJ, Ghose T, Chan CC, Falvey CF, Merrill JP (1972) A comparison of hyperacute canine renal allograft and sheep-to-dog xenograft rejection. Transplantation 13: 146–154PubMedCrossRefGoogle Scholar
  278. 278.
    MacDonald MK, Clarkson AR, Davison AM (1973) The role of coagulation in renal disease. Perspect Nephrol Hyptertens 2: 809–828Google Scholar
  279. 279.
    MacFarlane RG, Pilling J (1947) Fibrinolytic activity of normal urine. Nature 159: 779PubMedCrossRefGoogle Scholar
  280. 280.
    Maher JF, Lapierre L, Schreiner GE, Geiger M, Westervelt FB (1968) Regional heparinization for hemodialysis. N Engl J Med 268: 451–456CrossRefGoogle Scholar
  281. 281.
    Mandalaki T, Dessypris A, Louizon C, Bossinakou I, Panayotopoulou C, Antonopoulou A (1977) Marathon run: effects on blood coagulation an fibrinolysis. Thromb Haemost 37: 444–450PubMedGoogle Scholar
  282. 282.
    Mandel SR, Shermer R, Clark R, Staab EV, Webster WP (1979) Thrombosis: a study of coagulation parameters and mechanisms during allograft rejection. Thromb Haemost 41: 553–566PubMedGoogle Scholar
  283. 283.
    Mann LT, Jensenius JC, Simonsen M, Abildgaard U (1969) Antithrombin III: protection against death after injection of thromboplastin. Science 166: 517–518PubMedCrossRefGoogle Scholar
  284. 284.
    Mannhalter C, Deutsch E, Kopsa H (1985) Clotting activities and antigen concentrations of contact factors in kidney disease. Thromb Res 39: 475–484PubMedCrossRefGoogle Scholar
  285. 285.
    Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmerman TS (1983) Deamino-8-d-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308: 8–12PubMedCrossRefGoogle Scholar
  286. 286.
    Mansfield AD (1972) Alteration in fibrinolysis associated with surgery and venous thrombosis. Br J Surg 59: 754–757PubMedCrossRefGoogle Scholar
  287. 287.
    Mant MJ, Garner King E (1979) Severe, acute disseminated intravascular coagulation: a reappraisal of its pathophysiology, clinical significance and therapy based on 47 patients. Am J Med 67: 557–563PubMedCrossRefGoogle Scholar
  288. 288.
    Marciniak E, Gockerman JP (1977) Heparin induced clearance in circulating antithrombin III. Lancet II: 581–584CrossRefGoogle Scholar
  289. 289.
    Markiewicz A (1971) Urokinase activity in acute renal failure. Pol Med J 10: 837–843PubMedGoogle Scholar
  290. 290.
    Mason RG, Chuang HYK, Fazal Mohammad S, Sharp DH (1978) Extracorporeal thrombogenesis and anticoagulation. Nijhoff, The Hague Boston London, pp 199–216Google Scholar
  291. 291.
    Mathew TH, Clyne DH, Nanra RS, Kincaid-Smith P, Saker BM, Morris PJ, Marshall VC (1974) A controlled trial of oral anticoagulants and dipyridamole in cadaveric renal allografts. Lancet I: 1307–1310CrossRefGoogle Scholar
  292. 292.
    Matlin RA, Gary NE (1974) Acute cortical necrosis, case report and review of the literature. Am J Med 56: 110–118PubMedCrossRefGoogle Scholar
  293. 293.
    Matthew TH, Lewers DT, Hogan GP et al. (1971) The induction of vascular renal allograft rejection by leucocyte sensitization. J Lab Clin Med 77: 396–409PubMedGoogle Scholar
  294. 294.
    Matthias FR, Lasch HG (1982) Disseminierte intravaskuläre Gerinnung und Kreislaufschock. Haemostaseologie 2: 60–67Google Scholar
  295. 295.
    McConnel D, Johnson JG, Young L, Holemans R (1966) Localization of plasminogen activator in kidney tissue. Lab Invest 15: 980–986Google Scholar
  296. 296.
    McKay DG (1969) Tissue damage in disseminated intravascular coagulation - mechanisms of localization of thrombi in the microcirculation. Thromb Diath Haemorrh [Suppl] 36: 67–81Google Scholar
  297. 297.
    McKay DG (1973) Blood coagulation and renal disease. Perspect Nephrol Hypertens 2: 771–828Google Scholar
  298. 298.
    McMillan R (1968) Heparin in delayed transplant function. Lancet I:1178–1180CrossRefGoogle Scholar
  299. 299.
    McMurray SD, Luft FC, Maxwell DR et al.(1978) Prevailing patterns and predictor variables in patients with acute tubular necrosis. Arch Intern Med 138: 950–955PubMedCrossRefGoogle Scholar
  300. 300.
    McNicol GP, Barakat AA, Douglas AS (1965) Plasma fibrinolytic activity in renal disease. Scott Med J 10: 189–194PubMedGoogle Scholar
  301. 301.
    Meade TW, Chakrabarti R, Haines AP, Stirling Y (1979) Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1:153–156PubMedCrossRefGoogle Scholar
  302. 302.
    Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y, Thompson SG (1980) Haemostatic function and cardiovascular death: early results of a prospective study. Lancet II: 1050–1053CrossRefGoogle Scholar
  303. 303.
    Melissari E, Scully MF, Paes T, Kakkar VV (1985) The influence of LMW heparin on the coagulation and fibrinolytic response to surgery. Thromb Res 37:115–126PubMedCrossRefGoogle Scholar
  304. 304.
    Menon IS, Dewar HA, Newell DJ (1968) Role of the kidney in fibrinolytic activity of the blood. Lancet I: 785–788CrossRefGoogle Scholar
  305. 305.
    Mettinger KL (1982) A study of hemostasis in ischemic cerebrovascular disease. V. A multivariate evaluation of risk indicators and predictors. Early results of a longitudinal study. Thromb Res 28: 521–532PubMedCrossRefGoogle Scholar
  306. 306.
    Mettinger KL, Egberg N (1982) A study of hemostasis in ischemic cerebrovascular disease. III. Abnormalities in vascular plasminogen activators, antiactivators and alpha-2 antiplasmin. Thromb Res 26: 203–210PubMedCrossRefGoogle Scholar
  307. 307.
    Miles AL, Rothschild Z, Griffin JH (1981) Dextran sulfate stimulated fibrinolytic activity in whole human plasma: dependence on the contact activation system and on a urokinase related antigen. Thromb Haemost 46: 211Google Scholar
  308. 308.
    Moberg AW, Shons AR, Gewürz H, Mozes M, Najarian JS (1971) Prolongation of renal xenografts by the simultaneous sequestration of performed antibody, inhibition of complement, coagulation and antibody synthesis. Transplant Proc 3: 538–541PubMedGoogle Scholar
  309. 309.
    Monserrat AJ, Murso AM, Tartas et al. (1981) Consumption coagulopathy in acute renal failure induced by hypolipotropic diets. Nephron 28: 276–284PubMedCrossRefGoogle Scholar
  310. 310.
    Mottin D, Rondeau E, Delarue F, Bens M, Doleris LM, Sraer JD (1984) Arachidonic acid metabolites of isolated glomeruli after thrombin induced intravascular coagulation: Role of cyclooxygenase and lipoxygenase metabolites. Eur J Clin Invest [Suppl] 14: 60Google Scholar
  311. 311.
    Müller-Berghaus G, Röka L, Lasch HG (1973) Induction of glomerular microdot formation by fibrin monomer infusion. Thromb Diath Haemorrh 29: 375–383PubMedGoogle Scholar
  312. 312.
    Müller-Berghaus G, Bohn E, Höbel W (1976) Activation of intravascular coagulation by endotoxin: the significance of granulocyte and platelets. Br J Haematol 33: 213–220PubMedCrossRefGoogle Scholar
  313. 313.
    Muntean W, Goriup U (1975) Disseminierte intravasale Gerinnung und akutes Nierenversagen bei einem Säugling. Wien Klin Wochenschr 7: 792–796Google Scholar
  314. 314.
    Myburgh JA, Cohen I, Gecelter L et al. (1969) Hyperacute rejection in human-kidney allografts-shwartzman or arthus reaction? N Engl J Med 281: 131–135PubMedCrossRefGoogle Scholar
  315. 315.
    Myhre-Jensen O (1971) Localisation of fibrinolytic activity in the kidney and urinary tract of rats and rabbits. Lab Invest 25: 403–411PubMedGoogle Scholar
  316. 316.
    Myhre-Jensen O, Lund B (1972) Fibrinolytic activity of renal transplants in rabbits relation to graft thrombosis and necrosis. Acta Pathol Microbiol Scand 80: 651–658Google Scholar
  317. 317.
    Myhre-Jensen O, Hansen ES, Buitrago B (1972) Renal microthrombosis. Acta Pathol Microbiol Scand 80: 403–411Google Scholar
  318. 318.
    Nakamura M, Takahashi K, Naora H, Tsunematsu T (1984) A monoclonal antibody against human urokinase: characterization of the epitope and its localization in human kidney. Cell Struct Funct 9: 167–179PubMedCrossRefGoogle Scholar
  319. 319.
    Neild GH, Ivory K, Williams DG (1983) Glomerular thrombi and infarction in rabbits with serum sickness following cyclosporine therapy. Transplant Proc 15: 2782–2786Google Scholar
  320. 320.
    Neild GH, Rocchi G, Imberti L, Fumagalli F, Brown Z, Remuzzi G, Williams DG (1983) Effect of cyclosporin A on prostacyclin synthesis by vascular tissue. Thromb Res 32: 373–379PubMedCrossRefGoogle Scholar
  321. 321.
    Neild GH, Reuben R, Hartley RB, Cameron JS (1985) Glomerular thrombi in renal allografts associated with cyclosporin treatment. J Clin Pathol 38: 253–258PubMedCrossRefGoogle Scholar
  322. 322.
    Nelson PH, Moser KM, Stoner C, Moser KS (1982) Risk of complication during intravenous heparin therapy. West J Med 136: 189–197PubMedGoogle Scholar
  323. 323.
    Nemerson Y (1983) Regulation of the initiation of coagulation by factor VII. Haemostasis 13: 150–155PubMedGoogle Scholar
  324. 324.
    Nenci GG, Berrettini M, Agnelli G, Parise P, Buoncristiani U, Ballatori E (1979) Effect of peritoneal dialysis haemodialysis and kidney transplantation on blood platelet function. Nephron 23: 287–292PubMedCrossRefGoogle Scholar
  325. 325.
    Niewiarowski S (1981) Platelet release reaction and secretal platelet proteins. In: Bloom AL, Thomas DP (eds) Haemostasis and thrombosis. Churchill Livingstone, Edinburgh London New York, pp 73–83Google Scholar
  326. 326.
    Niewiarowski S, Prokopowicz J, Poplawski A, Worowski K (1964) Inhibition of dog fibrinolytic system in experimental tubular necrosis of kidney. Experientia 20: 101–103PubMedCrossRefGoogle Scholar
  327. 327.
    Nilsen DWT, Jeremic M, Weisert OK (1980) An attempt at predicting post-operative deep vein thrombosis by preoperative coagulation studies in patients undergoing total hip replacement. Thromb Haemost 43: 194–197PubMedGoogle Scholar
  328. 328.
    Nishimoto K, Yamagami S, Katoh Y, Kishimoto T, Maekawa M, Okada K, Matsuo O (1986) Coagulation and fibrinolysis in chronic renal failure. Change in tissue-type plasminogen activator activity. ASAIO Trans 32: 478–481PubMedCrossRefGoogle Scholar
  329. 329.
    Nordoy A, Visk-Mo H, Mjös OD, Johnson R (1977) Free fatty acids in plasma and platelets following low and high-dose heparin during alimentary hyperlipaemia. Acta Med Scand 202: 163–171PubMedCrossRefGoogle Scholar
  330. 330.
    Nossel HL (1976) Radioimmunoassay of fibrinopeptides in relation to intravascular coagulation and thrombosis. N Engl J Med 295: 428–432PubMedCrossRefGoogle Scholar
  331. 331.
    Notohamiprodjo M, Andrassy K, Bommer J, Ritz E (1986) Dialysis membranes and coagulation systems. Blood Purif 4: 130–141PubMedCrossRefGoogle Scholar
  332. 332.
    Oehler G, Matthias FR, Lasch HG (1986) Gerinnungsveränderungen im Schock. Behring Inst Mitt 7: 142–153Google Scholar
  333. 333.
    Olson JL (1984) Role of heparin as a protective agent following reduction of renal mass. Kidney Int 25: 376–382PubMedCrossRefGoogle Scholar
  334. 334.
    Ono I, Ohura T, Azami K, Hoshi M, Hasegawa T (1984) Anticoagulation therapy for renal insufficiency after burns. Burns 11: 104–110CrossRefGoogle Scholar
  335. 335.
    Ostendorf P, Jaschonek K, Daiß W (1985) Disseminierte intravasale Gerinnung (DIC) und Verbrauchskoagulopathie. Hämostaseologie 5: 44–53Google Scholar
  336. 336.
    Österud B, Björklid E (1982) The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. Scand J Haematol 29: 175–184PubMedCrossRefGoogle Scholar
  337. 337.
    Panicucci F, Sagripanti A, Pinori E, Vispi M, Lecchini L, Barsotti G, Giovannetti S (1983) Comprehensive study of haemostasis in chronic uraemia. Nephron 33: 5–8PubMedCrossRefGoogle Scholar
  338. 338.
    Partecke BD, Fischer C, Buck-Gramcko D (1985) Antithrombin III - ein wichtiger Faktor bei langdauernden mikrovaskulären Operationen. Handchirurgie 17: 81–85Google Scholar
  339. 339.
    Paye Y, Lehot JJ, Rousselet B (1983) High-bleeding risk in acute renal failure: hemodialysis with dipyridamole as the sole antithrombotic agent. Agressologie 24: 601–603Google Scholar
  340. 340.
    Persson E, Nordenström J, Nilsson-Ehle P, Hagenfeldt L (1985) Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin. Eur J Clin Invest 15: 215–220PubMedCrossRefGoogle Scholar
  341. 341.
    Pinaick RV, Wiegmann TB, Diederich DA (1983) Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 308: 258–261CrossRefGoogle Scholar
  342. 342.
    Pineo GF, Regoeczi E, Dempster WJ (1970) The nature of experimental second-set kidney transplant rejection. 1. The role of coagulation in hyperacute (second-set) renal allotransplant rejection in dogs. Br J Exp Pathol 51: 547–562PubMedGoogle Scholar
  343. 343.
    Pixley RA, Schapira M, Colman RW (1985) The regulation of human factor XII a by proteinase inhibitors. J Biol Chem 260: 1723–1729PubMedGoogle Scholar
  344. 344.
    Ponticelli C, Ruggeri ZM, Gordon YB et al.(1979) Urinary excretion of factor-VIII-related antigen and fibrin(ogen) degradation fragments D and E after kidney transplantation. Transplant Proc 11: 448–451PubMedGoogle Scholar
  345. 345.
    Porter KA (1967) Rejection in treated renal allografts. J Clin Pathol [Suppl] 20: 518–534Google Scholar
  346. 346.
    Preston FE, Ward AM (1972) Acute renal failure in myelomatosis from intravascular coagulation. Br Med J I: 604–605CrossRefGoogle Scholar
  347. 347.
    Previato G, Loschiavo C, Lupo A et al. (1981) Clinical significance of plasma factor VIII levels in renal disease. Clin Nephrol 16: 200–206PubMedGoogle Scholar
  348. 348.
    Prowse CV, Cash JD (1984) Physiologic and pharmacologic enhancement of fibrinolysis. Semin Thromb Hemost 10: 51–60PubMedCrossRefGoogle Scholar
  349. 349.
    Prydz H, Lyberg T (1980) Tissue thromboplastin - molecular and cellular biology. Protides Biol Fluids 28: 241–244Google Scholar
  350. 350.
    Pultavituma A, Azcarate J, Mammen EF, Rosenberg B, Rosenberg JC (1972) Coagulation and platelet changes in rejected renal allografts. Arch Surg 105: 255–259PubMedGoogle Scholar
  351. 351.
    Purkerson ML, Joist JH, Greenberg JM, Kay D, Hoffsten PE, Klahr S (1982) Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats. Thromb Res 26: 227–240PubMedCrossRefGoogle Scholar
  352. 352.
    Rabiner SF (1972) Uremic bleeding. Prog Hemost Thromb 1: 233–250PubMedGoogle Scholar
  353. 353.
    Rabiner SF (1972) Bleeding in uremia. Med Clin North Am 56: 221–233PubMedGoogle Scholar
  354. 354.
    Radegran K, Cronestrand R, Olsson P (1970) The effect of regional thrombin infusion on the renal vascular resistance. Eur Surg Res 2: 460–472PubMedCrossRefGoogle Scholar
  355. 355.
    Rammer L (1973) Renal function after intravascular coagulation in the rat kidney. Urol Res 1: 166–169PubMedCrossRefGoogle Scholar
  356. 356.
    Rammer L, Gerdin B (1975) Protection against the impairment of renal function after intravascular coagulation in the rat kidney by increased ingestion of sodium chloride. Nephron 14: 433–441PubMedCrossRefGoogle Scholar
  357. 357.
    Rammer L, Stahl E (1979) Effect of beta-adrenergic blockade by propanolol upon intravascular coagulation in the rat kidney. Nephron 24: 246–249PubMedCrossRefGoogle Scholar
  358. 358.
    Rao KV, Smith EJ, Alexander JW, Fidler JP, Pemmaraju SR, Pollack VE (1976) Thromboembolic disease in renal allograft recipients. Arch Surg 111: 1086–1092Google Scholar
  359. 359.
    Rath CE, Mailliard JA, Schreiner GE (1957) Bleeding tendency in uremia. N Engl J Med 257:808–811PubMedCrossRefGoogle Scholar
  360. 360.
    Ratnoff OD (1969) Epsilon aminocaproic acid-a dongerous weapon. N Engl J Med 280: 1124–1125PubMedCrossRefGoogle Scholar
  361. 361.
    Reddy KNN, Kine DL (1980) Plasminogen activators. In: Kline DL, Reddy KNN (eds) Fibrinolysis. CRC Press, Boca Raton, pp 25–41Google Scholar
  362. 362.
    Reeve EB (1980) Steady state relations between factors X, Xa, II, IIa, antithrombin III and alpha-2 macroglobulin in thrombosis. Thromb Res 18: 19–31PubMedCrossRefGoogle Scholar
  363. 363.
    Regoeczi E, Brain MC (1969) Organ distribution of fibrin in disseminated intravascular coagulation. Br J Haematol 17: 73–81PubMedCrossRefGoogle Scholar
  364. 364.
    Reiner AP, Bell WR (1984) The fibrinolytic system in man. CRC Crit Rev Oncol Hematol 2: 33–81CrossRefGoogle Scholar
  365. 365.
    Remmele W, Harms D (1968) Zur pathologischen Anatomie des Kreislaufschocks beim Menschen. Klin Wochenschr 46: 352–357PubMedCrossRefGoogle Scholar
  366. 366.
    Remuzzi G, Bertani T, Mecca G, Donati MB, de Gaetano D (1978) Factor VIII- related protein on vascular intima of patients with chronic renal failure and prolonged bleeding times. Br Med J I: 70–72CrossRefGoogle Scholar
  367. 367.
    Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G (1978) Bleeding in renal failure, altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 22: 347–353PubMedCrossRefGoogle Scholar
  368. 368.
    Remuzzi G, Benigni A, Dodesini P et al. (1982) Platelet function in patients on maintenance hemodialysis depressed or enhanced? Clin Nephrol 17: 60–63PubMedGoogle Scholar
  369. 369.
    Remuzzi G, Benigni A, Dodesini P et al. (1983) Reduced platelet thromboxane formation in uremia. J Clin Invest 71: 762–768PubMedCrossRefGoogle Scholar
  370. 370.
    Ribes EA, Domenech JC, Nicolas JMM, Gaspar ML (1975) Risk of acute renal failure associated with disseminated intravascular coagulation. Br Med J 3: 745CrossRefGoogle Scholar
  371. 371.
    Rick ME, Hoyer LW (1977) Thrombin activation of factor VIII: the effect of inhibitors. Br J Haematol 36: 585–597PubMedCrossRefGoogle Scholar
  372. 372.
    Riesmann D (1907) Hemorrhages in the course of Blight’s disease with especial reference to the occurence of a hemorrhagic diathesis of nephrotic origin. Am J Med Sci 134: 709–714CrossRefGoogle Scholar
  373. 373.
    Rondeau E, Angles-Cano E, Delarue F, Sultan Y, Sraer JD (1986) Polyunsaturated fatty acids increase fibrinolytic activity of human isolated glomeruli. Kidney Int 30: 701–705PubMedCrossRefGoogle Scholar
  374. 374.
    Rosenberg JC, Broersma RJ, Bullemer G, Mammen EF, Lenagham R, Rosenberg BF (1969) Relationship of platelets, blood coagulation, and fibrinolysis to hyperacute rejection of renal xenografts. Transplantation 8: 152–161PubMedCrossRefGoogle Scholar
  375. 375.
    Rosenberg RD (1975) Actions and interactions of antithrombin and heparin. N Engl J Med 292: 146–151PubMedCrossRefGoogle Scholar
  376. 376.
    Rothberger H, Barringer M, Meredith J (1984) Increased tissue factor activity of monocytes/macrophages isolated from canine renal allografts. Blood 63: 623–628PubMedGoogle Scholar
  377. 377.
    Rothberger H, Meredith J, Mutton T, Brown J, McGee MP (1985) Increased tissue factor activity generation in vitro by canine blood leukocytes associated with allogeneic kidney transplantation and rejection. Thromb Haemost 51: 1–4Google Scholar
  378. 378.
    Rowlands DT, Hill GS, Zmijewski CM (1976) The pathology of renal homograft rejection. Am J Pathol 85: 774–803Google Scholar
  379. 379.
    Ruggeri ZM, Gordon YB, Ardaillou N et al. (1979) Urinary excretion of factor VIII after renal transplantation. Br Med J I: 300–303CrossRefGoogle Scholar
  380. 380.
    Sakariassen KS, Bolhuis PA, Sixma JJ (1979) Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 279: 636–638PubMedCrossRefGoogle Scholar
  381. 381.
    Salaman JR (1970) Use of radioactive fibrinogen for detecting rejection of human renal transplants. Br Med J II: 517–521CrossRefGoogle Scholar
  382. 382.
    Salaman JR (1972) A technique for detecting rejection episodes in human transplant recipients using radioactive fibrinogen. Br J Surg II: 138–142CrossRefGoogle Scholar
  383. 383.
    Salzman EW, Neri LL (1966) Adhesiveness of blood platelets in uremia. Thromb Diath Haemorrh 15: 84–92PubMedGoogle Scholar
  384. 384.
    Sampol J, Robert A, Jahjah F, Gillet A, Olmer M (1982) Factor VIII related antigen, coagulation tests and acute renal failure. Proc Eur Dial Transplant Assoc Eur Ren Assoc 19: 325–328Google Scholar
  385. 385.
    Sanchez-Ibarrola A, Quazzaz S, Naish P (1981) Clearance of fibrin from glomeruli. Renal cortical fibrinolytic response after thromboplastin infusion in the rat. Clin Sci 60: 47–53PubMedGoogle Scholar
  386. 386.
    Scherf H, Nies AS, Schwertschlag U, Hughes M, Gerber JG (1986) Hemodynamic effects of platelet activating factor in the dog kidney in vivo. Hypertension 8: 737–741PubMedGoogle Scholar
  387. 387.
    Schipper HG, Roos JVD, Meulen F, ten Cate JW (1981) Antithrombin III deficiency in surgical intensive care patients. Thromb Res 21: 73–80PubMedCrossRefGoogle Scholar
  388. 388.
    Schräder J, Rumpf KW (1984) Gerinnungs-Hämatologie. Nieren Hochdruckkr 13: 296–306Google Scholar
  389. 389.
    Schräder J, Scheler F (1985) Coagulation disorders in acute renal failure. In: Sieberth H-G, Mann H (eds) Continous arterio-venous hemofiltration. Karger, Basel, pp 25–36Google Scholar
  390. 390.
    Schräder J, Köstering H, Züchner C, Caumanns J, Scheler F (1983) Methoden zur Bestimmung des Antithrombin III. Ärztl Lab 29: 35–39Google Scholar
  391. 391.
    Schräder J, Gallimore MJ, Eisenhauer T, Brüggemann M, Redlin E, Köstering H, Scheler F (1985) Studies on components of the coagulation, plasma kallikrein and firbinolytic systems in renal transplant patients. Thromb Haemost 54: 253Google Scholar
  392. 392.
    Schräder J, Valentin R, Tönnes HJ et al. (1985) Low molecular weight heparin in hemodialysis and hemofiltration patients. Kidney Int 28: 823–829PubMedCrossRefGoogle Scholar
  393. 393.
    Schräder J, Kandt M, Züchner C, Köstering H, Scheler F (1986) Comparison of unfractionated heparin and low molecular weight heparin during long term use in chronic haemodialysis and haemofiltration patients. Haemostasis [Suppl 2] 16: 48–58Google Scholar
  394. 394.
    Schräder J, Köstering H, Scheler F (1986) Bedeutung von Antithrombin III bei Nierenerkrankungen. Behring Inst Mitt 79: 216–230PubMedGoogle Scholar
  395. 395.
    Schräder J, Neuhaus KL, Tebbe U, Köstering H, Scheler F (1986) Fibrinolytic activity in renal venous blood in man. Klin Wochenschr 64: 587–589PubMedCrossRefGoogle Scholar
  396. 396.
    Schräder J, Köstering H, Scheler F (1987) Hämostasestörungen bei Nierenerkrankungen. In: Mammen EF (Hrsg) Intensivmedizin aktuell. Medizinische Verlagsgesellschaft, Marburg, S 99–111Google Scholar
  397. 397.
    Schräder J, Stibbe W, Armstrong VW, Kandt M, Muche R, Köstering H, Seidel D, Scheler F (in press) Comparison of low molecular weight heparin to standard heparin in a randomized long-term study on haemodialysis/haemofiltration patients. Kidney IntGoogle Scholar
  398. 398.
    Schultze G, Heitz J, Krais T, Neumayer HH, Wagner K, Molzahn M (1984) The impact of eicosanoids on compliance, cardiovascular performance, and coagulation during hemodialysis. Biomed Biochim Acta 43: 426–429Google Scholar
  399. 399.
    Schuster HP, Long MW, Blair J, Sedensky JA, Mammen EF (1980) The influence of disseminated intravascular coagulation on renal function after experimental hemorrhagic shock. Resuscitation 8: 3–28PubMedCrossRefGoogle Scholar
  400. 400.
    Schwartz BS, Levy GA, Curtiss LK, Fair DS, Edington TS (1981) Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. Two procoagulant activities are produced by peripheral blood mononuclear cells. J Clin Invest 67: 1650–1658PubMedCrossRefGoogle Scholar
  401. 401.
    Scott WL, Francis CW, Knutson DW, Marder VJ (1986) Specific indentification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation. J Lab Clin Med 107: 534–543PubMedGoogle Scholar
  402. 402.
    Scully MF, Kakkar W (1979) Chromogenic peptide substrates. Churchill Livingstone, Edinburgh London New YorkGoogle Scholar
  403. 403.
    Seitz R, Michalik R, Egbring R, Karges HE, Lange H (1984) Impaired fibrinolysis after kidney transplantation. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21: 941–944Google Scholar
  404. 404.
    Seitz R, Michalik R, Karges HE, Lange H, Egbring R (1986) Impaired fibrinolysis and protein c increase after cadaver kidney transplantation. Thromb Res 42: 277–288PubMedCrossRefGoogle Scholar
  405. 405.
    Shah BC, Ambrus JL, Mink IB, Albert DJ, Sampson D, Murphy GP (1972) Fibrin degradation products in renal parenchymal disease states and renal transplant patients. Transplantation 14: 705–710PubMedCrossRefGoogle Scholar
  406. 406.
    Shakespeare M, Wolf P (1979) The demonstration of urokinase antigen in whole blood. Thromb Res 14: 825–835PubMedCrossRefGoogle Scholar
  407. 407.
    Sharma HM, Moore S, Merrick HW, Smith MR (1972) Platelets in early hyperacute allograft rejection in kidneys and their modification by sulfinpyrazone (Anturan) therapy. Am J Pathol 66: 445–453PubMedGoogle Scholar
  408. 408.
    Sharma MSC, Saim MJS (1981) Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in hypertension. Thromb Haemost 45:100–108PubMedGoogle Scholar
  409. 409.
    Shelley WB, Juhlin L (1977) Induction of fibrin thrombi by monocytes. Nature 270:343–344PubMedCrossRefGoogle Scholar
  410. 410.
    Shetty HG, Almeida A, Sheth SM, Chawla KP, Acharya VN (1982) Coagulation studies in uraemia. J Postgrad Med 28: 149–159PubMedGoogle Scholar
  411. 411.
    Shulman H, Striker G, Deeg HJ, Kennedy M, Strob R, Thomas ED (1981) Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation. N Engl J Med 305: 1392–1395PubMedCrossRefGoogle Scholar
  412. 412.
    Sieberth HG, Kindler J, Vlaho M, Glöckner WM, Freiberg J, Pelzer R (1982) Langzeitergebnisse der chronisch-intermittierenden Dialysebehandlung. Med Welt 33: 1363–1366PubMedGoogle Scholar
  413. 413.
    Siefring GE, Castellino FJ (1975) De novo biosynthesis of plasminogen in the anephric rat. J Appl Physiol 38: 114–116PubMedGoogle Scholar
  414. 414.
    Siegal T, Seligsohn U, Aghai E, Modan M (1978) Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases. Thromb Haemost 39: 122–134PubMedGoogle Scholar
  415. 415.
    Silberbauer KF, Wolf A, Stummvoll HK, Sinzinger H, Ring F, Pinggera WF (1979) Zirkulierende Thrombozytenaggregate während Hämodialyse. Klin Wochenschr 57: 1137–1138PubMedCrossRefGoogle Scholar
  416. 416.
    Simon P, Ang KS, Cam G (1987) Enhanced platelet aggregation and membrane biocompatibility: possible influence on thrombosis and embolism in hemodialysis patients. Nephron 45: 172–173PubMedCrossRefGoogle Scholar
  417. 417.
    Simpson KM, Bunch DL, Amemiya H et al. (1970) Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery 68: 77–85PubMedGoogle Scholar
  418. 418.
    Sixma JJ, Sakariassen KS, Stel HV, Houdijk WPM (1984) Functional domains of von Willebrand factor. J Clin Invest 74: 736–744PubMedCrossRefGoogle Scholar
  419. 419.
    Slapak M, Greenbaum M, Bardawil W, Saravis C, Joison J, McDermott WV (1971) Effect of heparin, arvin, liver perfusion, and heterologous antiplatelet serum on rejection of pig kidney by dog. Transplant Proc 3: 558–561PubMedGoogle Scholar
  420. 420.
    Smith N, Candler S, Hawker RJ, Hawker LM, Barnes AD (1979) Indium labelled autologous platelets as diagnostic aid after renal transplantation. Lancet II: 1241–1242CrossRefGoogle Scholar
  421. 421.
    Smith-Erichsen N, Aasen AO (1984) Evaluation of severity and prognosis in early stages of septicemia by means of chromogenic peptide substrate assays. Eur Surg Res [Suppl 2] 16: 140–146CrossRefGoogle Scholar
  422. 422.
    Smith-Erichsen N, Aasen AO, Gallimore M J, Amundsen E (1982) Studies of components of the coagulation systems in normal individuals and septic shock patients. Circ Shock 9: 491–497PubMedGoogle Scholar
  423. 423.
    Smokovitis A, Maier M, Binder BR (1984) Comparison between vascular plasminogen activator activity and changes in blood flow in the renal cortex in pigs. Thromb Haemost 51: 150–153PubMedGoogle Scholar
  424. 424.
    Smokovitis A, Wagner M, Starlinger M, Opitz A, Binder BR (1985) Changes in plasminogen activator activity and plasmin inhibitor in the pig during experimental hypovolaemia. Thromb Haemost 52: 130–133Google Scholar
  425. 425.
    Sobel GW, Möhler SR, Jones NW, Dowdy ABC, Guest MM (1952) Urokinase: an activator of plasma profibrinolysis extracted from urine. Am J Physiol 171: 768–769Google Scholar
  426. 426.
    Solez K, Morel-Maroger L, Sraer JD (1979) The morphology of „acute tubular necrosis“ in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine 58: 362–376PubMedCrossRefGoogle Scholar
  427. 427.
    Soper WD, Pollak R, Manaligod JR, Hau T, Mozes MF, Jonasson O (1982) Use of anticoagulation in cadaver renal transplants. J Surg Res 32: 370–376PubMedCrossRefGoogle Scholar
  428. 428.
    Spagnuolo PJ, Bass SH, Smith MC, Danviriyasup K, Dunn MJ (1982) Neutrophil adhesiveness during prostacyclin and heparin hemodialysis. Blood 60: 924–929PubMedGoogle Scholar
  429. 429.
    Spero JA, Lewis JH, Hasiba U (1980) Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost 43: 28–33PubMedGoogle Scholar
  430. 430.
    Sraer JD, Delarue F, Dard S, De Seigneux R, Morel-Maroger L, Kanfer A (1975) Glomerular fibrinolytic activity after thrombin perfusion in the rat. Lab Invest 32: 515–517PubMedGoogle Scholar
  431. 431.
    Sraer JD, Blanc E, Delarue F, Kanfer A, Ardaillou R, Richet G (1979) Effect of calcium and hydrogen ion on the fibrinolytic activity of isolated renal glomeruli from rat. Kidney Int 15: 238–245PubMedCrossRefGoogle Scholar
  432. 432.
    Stahl E, Gerdin B, Rammer L (1981) Protective effect of angiotensin II inhibition on acute renal failure after intravascular coagulation in the rat. Nephron 29: 250–257PubMedCrossRefGoogle Scholar
  433. 433.
    Stahl E, Karlberg BE, Rammer L (1982) Fibrin deposition in the kidney and renal blood flow during intravascular coagulation in the rat: influence of the renin-angiotensin system. Clin Sei 62: 35–41Google Scholar
  434. 434.
    Stahl E, Boberg U, Larsson L, Rammer L, Persson AEG (1983) Effect of renal tubular obstruction on stop-flow pressure and glomerular deposition of fibrin during intravascular coagulation in the rat. Kidney Int 24: 323–329PubMedCrossRefGoogle Scholar
  435. 435.
    Starzl TE, Lerner RA, Dixon FJ, Groth CG, Brettschneider L, Terasaki PI (1968) Shwartzman reaction after human renal homotransplantation. N Engl J Med 278: 642–648PubMedCrossRefGoogle Scholar
  436. 436.
    Starzl TE, Boehmig HJ, Amemiya H et al.(1970) Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med 283: 383–390PubMedCrossRefGoogle Scholar
  437. 437.
    Stewart JH, Castaldi PA (1967) Uraemic bleeding: a reversible platelet defect corrected by dialysis. Q J Med 36: 409–423PubMedGoogle Scholar
  438. 438.
    Stewart JH, Farrell PC, Dixon M (1975) Reduction of platelet/fibrin deposition in haemodialysis by aspirin administration. Aust NZ J Med 5: 117–122CrossRefGoogle Scholar
  439. 439.
    Sueishi K, Nanno S, Okamura T, Inoue S, Tanaka K (1982) Purification and characterization of human kidney plasminogen activators dissimilar to urokinase. Biochim Biophys Acta 717: 327–336PubMedCrossRefGoogle Scholar
  440. 440.
    Sundsmo JS, Fair DS (1983) Relationships among the complement, kinin, coagulation and fibrinolytic systems in the inflammatory reaction. Clin Physiol Biochem 1: 225–284PubMedGoogle Scholar
  441. 441.
    Swartz RD (1981) Hemorrhage during high-risk hemodialysis using controlled heparinization. Nephron 28: 65–69PubMedCrossRefGoogle Scholar
  442. 442.
    Swartz RD, Port FK (1979) Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin. Kidney Int 16: 513–518PubMedCrossRefGoogle Scholar
  443. 443.
    Szczeklik A, Kopec M, Sladek K, Musial J, Chmielewska J (1983) Prostacyclin and the fibrinolytic system in ischemic vascular disease. Thromb Res 29: 655–660PubMedCrossRefGoogle Scholar
  444. 444.
    Taenaka N, Shimada Y, Hirata T, Nishijima M, Yoshiya I (1982) New approach to regional anticoagulation in hemodialysis using gabexate mesilate (Foy). Crit Care Med 10: 773–775PubMedCrossRefGoogle Scholar
  445. 445.
    Takemoto Y, Tanabe J, Tanaka S, Fukuda A, Fujii C, Kohama A, Shibata S (1985) The effect of prophylactic heparinization on DIC arising from transitory circulatory arrest in dogs. Circ Shock 15: 131–139PubMedGoogle Scholar
  446. 446.
    Teien AN, Li M, Abildgaard U (1976) Assay of heparin in plasma using a chromogenic substrate for activated factor X. Thromb Res 8: 413–416PubMedCrossRefGoogle Scholar
  447. 447.
    Terada Y, Ueno A (1983) Hyperacute renal allograft rejection in the rabbit. Transplantation 35: 205–208PubMedCrossRefGoogle Scholar
  448. 448.
    Terao T, Kobayashi T (1983) The role of placental urokinase inhibitor in toxemia of pregnancy. Biol Res Pregnancy 4: 145–151Google Scholar
  449. 449.
    Thaler E, Lechner K (1981) Antithrombin III deficiency and thromboembolism. Clin Haematol 10: 369–390PubMedGoogle Scholar
  450. 450.
    Theiss W, Graeff H, Bleyl U, Immich H, Kuhn W (1970) Reversible Stadien intra-vaskularer Gerinnung und ihre Auswirkungen auf Nierenfunktion und Urokina-seausscheidung. Thromb Diath Haemorrh 23: 369–385PubMedGoogle Scholar
  451. 451.
    Thiagarajan P, Niemetz J (1980) Procoagulant tissue factor activity of circulating peripheral blood leukocytes. Results of in vivo studies. Thromb Res 17: 891–896PubMedCrossRefGoogle Scholar
  452. 452.
    Thomson AW, Webster LM, Aldridge RD, Morrice LM (1985) Cyclosporin and leucocyte procoagulant activity. Lancet I: 1396CrossRefGoogle Scholar
  453. 453.
    Timor-Tritsch I, Better OS, Tatarsky I, Chaimowitz C, Peretz A, Abramovici H (1970) Successful treatment of post-partum renal failure with heparin. Br Med J 4: 221–222PubMedCrossRefGoogle Scholar
  454. 454.
    Todd AS, Hargreaves LN (1975) Identification of plasminogen activator in tissues. Prog Chem Fibrin Thromb 1: 217–224Google Scholar
  455. 455.
    Tracy PB, Rohrbach MS, Mann KG (1983) Functional prothrombinase complex assembly on isolated monocytes and lymphocytes. J Biol Chem 258: 7264–7267PubMedGoogle Scholar
  456. 456.
    Triantaphyllopoulos DC (1984) Effects of human antithrombin III on mortality and blood coagulation induced in rabbits by endotoxin. Thromb Haemost 51: 232–235PubMedGoogle Scholar
  457. 457.
    Triantaphyllopoulos DC, Cho MS (1986) Effect of injection of CI inactivator on the platelet count and blood coagulation in rabbits infused with endotoxin. Thromb Haemost 55: 293PubMedGoogle Scholar
  458. 458.
    Tsao BP, Fair DS, Curtiss LK, Edington TS (1984) Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VH/VIIa protease activity. J Exp Med 159: 1042–1049PubMedCrossRefGoogle Scholar
  459. 459.
    Tuddenham EGD, Lazarchick J, Hoyer LW (1981) Synthesis and release of factor VIII by cultured human endothelial cells. Br J Haematol 47: 617–626PubMedCrossRefGoogle Scholar
  460. 460.
    Turney JH, Woods HF, Fewell MR, Weston MJ (1981) Factor VIII complex in uraemia and effects of haemodialysis. Br Med J II: 1653–1656CrossRefGoogle Scholar
  461. 461.
    Turney JH, Fewell M, Williams LC, Dodd N, Weston MJ (1982) Paradoxical behaviour of antithrombin III during hemodialysis and its prevention with prostacyclin. Clin Nephrol 17: 31–35PubMedGoogle Scholar
  462. 462.
    Vaage J (1982) Prediction of prognosis in intensive care patients. Acta Chir Scand [Suppl] 509: 73–75Google Scholar
  463. 463.
    Vanrenterghem Y, Lernt T, Roels L et al.(1985) Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet I: 999–1002CrossRefGoogle Scholar
  464. 464.
    Vassalli P, McCluskey RT (1965) The coagulation process and glomerular disease. Am J Med 39: 179–183PubMedCrossRefGoogle Scholar
  465. 465.
    Vaziri ND, Toohey J, Paule P, Alikhani S, Hung E (1984) Coagulation abnormalities in patients with end-stage renal disease treated with hemodialysis. Int J Artif Organs 7: 323–326PubMedGoogle Scholar
  466. 466.
    Viener A, Aviram M, Better OS, Brook JG (1986) Enhanced in vitro platelet aggregation in hemodialysis patients. Nephron 43: 139–143PubMedCrossRefGoogle Scholar
  467. 467.
    Vinazzer H (1986) Substitution of antithrombin III in shock and DIC. In: Böttiger LE (eds) Antithrombin deficiency. KabiVitrum, Stockholm pp 79–83Google Scholar
  468. 468.
    Vinazzer H, Blauhut B, Bergmann H (1984) Die Antithrombin Ill-Substitution bei Patienten im Schock. Folia Haematol 111: 806–816Google Scholar
  469. 469.
    Vygovskaya YI, Vorobel AV, Buzherak NF (1983) Kallikrein-kinin system of blood plasma in heterotransfusion backed by the use of heparin. Folia Haematol 110: 716–724Google Scholar
  470. 470.
    Wachtfogel YT, Kucich U, James HL et al. (1983) Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest 72: 1672–1677PubMedCrossRefGoogle Scholar
  471. 471.
    Wardle EN (1973) Intravascular coagulation in experimental acute renal failure. Thromb Diath Haemorrh 29: 579–591PubMedGoogle Scholar
  472. 472.
    Wardle EN (1974) Fibrin in renal disease: functional considerations. Clin Nephrol 2: 85–92PubMedGoogle Scholar
  473. 473.
    Wardle EN (1976) The functional role of intravscular coagulation in renal disease. Scott Med J 21: 83–91PubMedGoogle Scholar
  474. 474.
    Wardle EN, Uldall PR (1972) Effect of heparin on renal function in patients with oliguria. Br Med J 4: 135–138PubMedCrossRefGoogle Scholar
  475. 475.
    Wardle EN, Uldall PR, Swinney JS (1974) Radio-fibrinogen catabolism studies in human renal allograft recipients. Transplantation 18: 508–514PubMedCrossRefGoogle Scholar
  476. 476.
    Warrell RP, Hultin ME, Coller BS (1979) Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure. Am J Med 66: 226–228PubMedCrossRefGoogle Scholar
  477. 477.
    Watson AJS, Keogh JAB (1982) Effect of l-deamino-8-d-arginine vasopressin on the prolonged bleeding time in chronic renal failure. Nephron 32: 49–52PubMedCrossRefGoogle Scholar
  478. 478.
    Wegmüller E, Grüninger U, Furlan M, Beck EA, Hodler J, Reubi FC (1981) Factor VIII activity in chronic renal disease. Nephron 28: 157–162PubMedCrossRefGoogle Scholar
  479. 479.
    Weinstein MJ, Chute LE, Schmitt GW et al.(1985) Abnormal factor VIII coagulant antigen in patients with renal dysfunction and in those with disseminated intravascular coagulation. J Clin Invest 76: 1406–1411PubMedCrossRefGoogle Scholar
  480. 480.
    Wessel-Aas T, Blomhoff JP, Wirum E, Nilsen T (1984) Hemodialysis and cell toxicity in vitro related to plasma triglycerides, post-heparin lipolytic activity and free fatty acids. Acta Med Scand 216: 75–83PubMedCrossRefGoogle Scholar
  481. 481.
    Whitaker AN (1974) Acute renal failure in disseminated intravascular coagulation. Prog Biochem Pharmacol 9: 45–64PubMedGoogle Scholar
  482. 482.
    Whitaker AN, McKay DG, Csavossy J (1969) Studies of catecholamine shock. Am J Pathol 56: 153–179PubMedGoogle Scholar
  483. 483.
    Whitaker AN, Bunce IH, Nicoll P, Dowling SV (1973) Interaction of angiotensin with disseminated intravascular coagulation. Am J Pathol 72: 1–10PubMedGoogle Scholar
  484. 484.
    Whitaker AN, Bunce IH, Nicoll P, Emmerson BT (1973) Disseminated intravascular coagulation and intravascular hemolysis in glomerular disease. Perspect Nephrol Hypertens 2: 845–870Google Scholar
  485. 485.
    Whitfield LR, Levy G (1983) Pharmacokinetics of heparin V: in vivo and in vitro factors affecting the relationship between concentration and anticoagulant effect of heparin in rat plasma. J Pharm Sci 72: 1141–1146PubMedCrossRefGoogle Scholar
  486. 486.
    Wieding JU, Merten HA, Köstering H (1984) Modifizierte Fibrinmonomerkomplex-Bestimmung zur raschen und zuverlässigen Diagnostik von Umsatzsteigerungen im Gerinnungssystem. In: Beck EA (Hrsg) Thrombose- und Hämostaseforschung 1984. Schattauer, Stuttgart, S 397–398Google Scholar
  487. 487.
    Wijngaards G, Kluft C, Groeneveld E (1982) Demonstration of urokinase-related fibrinolytic activity in human plasma. Br J Haematol 51: 165–169PubMedCrossRefGoogle Scholar
  488. 488.
    Wijngaards G, Rijken DC, Wezel AL van, Groeneveld E, Velden CAM van der (1986) Characterization and fibrin-binding properties of different molecular forms of pro-urokinase from a monkey kidney cell culture. Thromb Res 42: 749–760PubMedCrossRefGoogle Scholar
  489. 489.
    Wilhelmsson S, Asaba H, Gunnarsson B, Kudryk B, Robinson D, Bergström J (1981) Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis. Clin Nephrol 15: 252–258PubMedGoogle Scholar
  490. 490.
    Winchester JF, Gelfand MC, Foegh ML, Hellrich GB, Schreiner GE (1983) Early indicators of renal allograft rejection. Kidney Int [Suppl 14] 23: 34–40Google Scholar
  491. 491.
    Winkelmann G, Meyer G, Roskamm H (1986) Der Einfluß körperlicher Belastung auf Blutgerinnung und Fibrinolyse bei untrainierten Personen und Hochleistungssportlern. Klin Wochenschr 13: 712–716Google Scholar
  492. 492.
    Winter M, Needham J, Mackie J, Cameron JS (1984) Impaired vessel wall response to venous occlusion in patients with chronic renal failure on maintenance hemodialysis. Clin Nephrol 22: 307–313PubMedGoogle Scholar
  493. 493.
    Woo KT (1985) Platelet injury and antithrombin III in clinical nephrology. Ann Acad Med 14: 394–403Google Scholar
  494. 494.
    Woo KT, Lee EJC, Lau YK, Lim CH (1985) Antithrombin III in renal transplant recipients. Thromb Res 38: 201–206PubMedCrossRefGoogle Scholar
  495. 495.
    Woo KT, Wei SS, Lee EJC, Lau YK, Lim CH (1985) Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets. Nephron 40: 25–28PubMedCrossRefGoogle Scholar
  496. 496.
    Woods HF, Weston MJ, Bunting S (1978) Haemodialysis without heparin. Proc Eur Dial Transplant Assoc Eur Ren Assoc 15: 122–129Google Scholar
  497. 497.
    Wun TC, Schleuning WD, Reid E (1982) Isolation and characterization of urokinase from human plasma. J Biol Chem 257: 3276–3283PubMedGoogle Scholar
  498. 498.
    Ygge J (1970) Changes in blood coagulation and fibrinolysis during the postoperative period. Am J Surg 119: 225–232PubMedCrossRefGoogle Scholar
  499. 499.
    Zaugg H (1980) Thromboplastic activity of human arterial walls and its interaction with the plasmatic coagulation system. J Clin Chem Clin Biochem 18: 545–549PubMedGoogle Scholar
  500. 500.
    Zazgornik J, Balcke P, Schmidt P, Kopsa H, Hysek H, Lenz K (1981) Alpha- 1-Antitrypsin und Fibrinogenspiegel bei chronischer Niereninsuffizienz und nach Nierentransplantation. Klin Wochenschr 59: 1261–1265PubMedCrossRefGoogle Scholar
  501. 501.
    Zimmerman SW (1986) Chronic peritoneal dialysis is associated with progressive thrombocytosis. Peritoneal Dial Bull 6: 71–73Google Scholar
  502. 502.
    Zühlke V, Quellhorst E, Hierholzer E, Mietzsch G (1972) Disseminierte intravasculäre Gerinnung nach allogener Nierentransplantation. Diagnostische Bedeutung und therapeutische Konsequenzen. Klin Wochenschr 50: 370–378PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • Joachim Schrader
    • 1
  1. 1.Zentrum für Innere MedizinUniversität GöttingenGöttingenGermany

Personalised recommendations